Factors Associated with Parental Treatment Attitudes and Information-Seeking Behaviors for Childhood ADHD by Taylor, Lea Elizabeth
Syracuse University 
SURFACE 
Theses - ALL 
January 2017 
Factors Associated with Parental Treatment Attitudes and 
Information-Seeking Behaviors for Childhood ADHD 
Lea Elizabeth Taylor 
Syracuse University 
Follow this and additional works at: https://surface.syr.edu/thesis 
 Part of the Social and Behavioral Sciences Commons 
Recommended Citation 
Taylor, Lea Elizabeth, "Factors Associated with Parental Treatment Attitudes and Information-Seeking 
Behaviors for Childhood ADHD" (2017). Theses - ALL. 146. 
https://surface.syr.edu/thesis/146 
This is brought to you for free and open access by SURFACE. It has been accepted for inclusion in Theses - ALL by an 
authorized administrator of SURFACE. For more information, please contact surface@syr.edu. 
 
 
 
Abstract 
 
Background: Childhood ADHD is an impairing neurodevelopmental disorder with associated 
long-term negative outcomes in a variety of domains. Despite this, there is a significant delay to 
treatment and a low rate of lifetime treatment contact for individuals with ADHD. Barriers to 
child treatment include parental poor symptom recognition, attitudinal barriers, evaluative 
barriers, fear of stigma, and structural barriers. These barriers are important to consider in the 
context of the family system, as parents serve as gatekeepers to mental health treatment for their 
children. In addition, parents’ perceptions of the quality and type of their children’s symptoms 
may also inform their information-seeking behaviors and ultimately, treatment decisions. The 
current study aimed to examine (a) variables associated with treatment-seeking attitudes, (b) 
variables associated with information-seeking behaviors, and (c) the relationship between 
treatment-seeking attitudes and information-seeking behaviors in a non-treatment-seeking parent 
sample.  
 
Method: Data from 169 non-treatment-seeking parents were analyzed. All parents participated in 
an online study that assessed their perceptions of their own children’s symptoms, parenting self-
efficacy, satisfaction with treatment providers for themselves and their child, knowledge about 
ADHD and treatment, symptom recognition, stigma towards ADHD, and treatment attitudes. 
Information-seeking behaviors were also measured.  
 
Results: Linear and logistic regressions analyzed the association between parental factors and 
treatment attitudes and information-seeking behavior, as well as the association between attitudes 
and information-seeking behavior. In these non-treatment-seeking parents, attitudes towards 
ADHD treatment were significantly associated with ADHD knowledge and misconceptions, 
causal attributions and understanding of ADHD, parenting self-efficacy, ADHD stigma, ADHD 
knowledge, and satisfaction with past providers. No hypothesized factors were significantly 
associated with information-seeking behavior. Attitudes towards treatment and information-
seeking behavior were also not significantly associated with each other.  
 
Discussion: Parental knowledge and understanding of ADHD symptoms and treatment, low 
levels of ADHD stigma, and positive experiences with past medical providers for oneself and 
one’s child were the best predictors of holding positive attitudes about ADHD treatment. 
Significant relations between these factors and treatment attitudes and information-seeking 
behavior did not emerge, however, highlighting the need for additional research on factors 
associated with treatment attitudes as well as continued study of how best to enhance treatment 
attitudes.  
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Factors Associated with Parental Treatment Attitudes and Information-Seeking Behaviors for 
Childhood ADHD 
ADHD 
ADHD background. The onset of many major mental health disorders, including 
attention deficit / hyperactivity disorder (ADHD), occurs during childhood and adolescence 
(Kessler et al., 2005b). The national comorbidity survey replication (NCS-R) study reported that 
half of all lifetime cases of psychiatric disorders occur before the age of 14, indicating that 
childhood represents an area of importance for research focusing on diagnosing and treatment-
seeking behaviors (Kessler et al., 2005b). Specifically, childhood ADHD represents a clinically 
important area of study due to its high prevalence, as high as 11% in some epidemiological 
studies (Visser et al., 2014), the severity of functional impairment associated with ADHD 
(Molina et al., 2009), the high prevalence of psychiatric comorbidities (Biederman, Newcorn, & 
Sprich, 1991; Jensen et al., 2007) and associated negative long-term consequences (Barkley, 
Fischer, Smallish, & Fletcher, 2006; Biederman et al., 1998a). Furthermore, ADHD poses a 
significant economic burden on the United States; in 2000 the estimated cost was $31.6 billion 
(Birnbaum et al., 2005). In short, ADHD is a prevalent, clinically significant disorder with a 
multitude of negative implications.  
ADHD is characterized by inattention, hyperactivity, and/or impulsive symptoms that 
cause significant functional impairment (American Psychiatric Association, 2013).  Several of 
these symptoms must be present before age 12. There is great heterogeneity in ADHD due to the 
wide variety of possible symptom combinations that may lead to a diagnosis (Wåhlstedt, Thorell, 
& Bohlin, 2009). ADHD symptoms are associated with significant impairment in diverse areas 
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such as educational, motivational, social, psychomotor, and emotional functioning, among other 
areas (Schipper et al., 2015).  
ADHD is the most commonly diagnosed and treated childhood psychiatric disorder 
(Akinbami, Liu, Pastor, & Reuben, 2011; Spencer, Biederman, & Mick, 2007). The National 
Health Interview Survey data revealed that the lifetime prevalence of children with ADHD 
increased 29% from 1998 to 2009 (Akinbami et al., 2011). Despite the high prevalence rate, the 
causes and development of ADHD is still contended and controversial (Ford-Jones, 2015; 
Schwarz, 2013). Although there is substantial body of work to support the diagnosis and 
treatment of ADHD as a disorder (Barkley, 2002), some argue that the diagnosis of ADHD 
represents an over-pathologization of normal personality traits (e.g., Szasz, 2003). 
Longitudinal persistence of ADHD. Previously thought to dissipate in adolescence, the 
persistence of ADHD into adulthood has been empirically supported (Wilens, Biederman, & 
Spencer, 2002). In typically developing children, hyperactivity symptoms decline, although 
inattentive symptoms persist (Spencer et al., 2007). Children with ADHD are at risk for later 
school failure, emotional difficulties, dysfunctional peer relationships and legal difficulties as 
adolescents (Spencer et al., 2007). The developmental trajectories of children with ADHD are 
quite heterogeneous with 20% of children functioning poorly at a 4-year follow-up, 20% 
functioning well, and 60% functioning intermediately (Biederman, Mick, & Faraone, 1998b; 
Spencer et al., 2007). However, not all children with ADHD will become adults with ADHD. 
The persistence of ADHD into adulthood is predicted by a variety of factors including symptom 
severity, maternal psychopathology, family size, psychiatric comorbidity and intelligence 
(Biederman et al., 1998b). ADHD is associated with significant psychiatric comorbidities such as 
oppositional defiant disorder (ODD), conduct disorder (CD), major depressive disorder (MDD), 
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and anxiety disorders, and predicts substance-use disorders, later poor academic performance, 
psychological maladjustment, employment difficulties, immaturity and divorce (Spencer et al., 
2007). Although ADHD is a condition that has the potential to cause significant long-term 
negative outcomes, there are a variety of evidence-based treatments that confer hope for parents 
and children with ADHD. 
ADHD etiological theory. Current research supports a variety of theories regarding the 
etiology of ADHD (Barkley, 1997; Sonuga-Barke, 2002) and each theory likely describes a 
subset of individuals with ADHD. ADHD is multidimensional and the large etiological literature 
cites many likely pathways to ADHD (Scassellati, Bonvicini, Faraone, & Gennarelli, 2012; von 
Rhein et al., 2015). For example, genetic transmission plays a significant role in the development 
of ADHD (Biederman & Faraone, 2005). Heritability data from twin and adoption studies 
demonstrates that genetic factors account for approximately 76 to 80% of the etiology for ADHD 
(Biederman & Faraone, 2002, 2005). Genome wide association studies have provided less 
consistent results with significant heterogeneity of genome regions for ADHD suggesting that it 
is unlikely that specific genome regions have large effects on the disorder globally (Biederman & 
Faraone, 2005). Heterogeneous genomic sites may contribute to some of the heterogeneity in the 
disorder.  
In addition, various neurotransmitters may be involved in the pathophysiology of ADHD. 
Individuals with ADHD may have a greater density of dopamine transporters (DAT) in their 
brain compared to those without ADHD (Dougherty et al., 1999). Effective pharmacological 
treatments for ADHD target the dopamine and norepinephrine systems, which similarly suggests 
that these systems are involved in the etiology of ADHD symptoms (Dougherty et al., 1999; 
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Dresel et al., 2000). For example, methylphenidate decreases the number of available DAT, and 
this decrease correlates with a reduction of ADHD symptoms (Dresel et al., 2000).  
In addition to biological theories, there are a variety of cognitive theories that attempt to 
explain ADHD. A review indicated that although theories of ADHD cite executive functioning 
deficits as central to ADHD, and that weaknesses in executive functioning are associated with 
ADHD, executive functioning deficits are not present in all children with ADHD (Lambek et al., 
2011); nonetheless, at the group level, when compared to those without ADHD, executive 
functioning impairment is characteristic of the disorder (Killeen, Tannock, & Sagvolden, 2012; 
Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). Many cognitive theories of ADHD 
propose that ADHD is related to insufficient brain activation and/or dysfunctions in 
neurophysiology. These insufficient activation patterns affect executive (i.e., planning, 
monitoring, detection of errors, and error correction), computational mechanisms of attention 
(i.e., encoding, search, decision, and motor organization), and energetic (i.e., effort, arousal, and 
activation) functioning (Sergeant, 2005).  
These cognitive, neurophysiological, and genetic factors likely account for much, but not 
all, of the risk for developing ADHD. There are likely complex interactions between underlying 
biological factors that interact with environmental variables to lead to ADHD. Prenatal exposure 
to nicotine and alcohol, low birth weight, low socioeconomic status (SES), parental 
psychopathology, comorbid disruptive behavior disorders in parents and offspring, and paternal 
criminality, may also be risk factors for ADHD (Biederman & Faraone, 2002, 2005). 
Additionally, some theories suggest that ADHD arises from environmental toxins such as lead 
when combined with other underlying risk factors (Nigg, Nikolas, Knottnerus, Cavanagh, & 
Friderici, 2010). However, ADHD occurs in similar rates in countries where these toxins are 
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common and uncommon (Killeen et al., 2012). Despite the popularization of the idea that 
different diets (e.g., high sugar content foods) may cause ADHD, this theory has been widely 
debunked (Biederman & Faraone, 2005). Finally, maladaptive reinforcement of impulsive, 
hyperactive, and inattentive behaviors through immediate gratification may help explain the 
maintenance of ADHD symptoms (Aase & Sagvolden, 2005). Overall, although there may be 
important environmental triggers, these theories do not explain the etiology of ADHD alone. 
Likely, there are complex interactions between biopsychosocial factors that lead to the 
development of ADHD. The above theories are both informed by and guide the evidence-based 
treatments.  
ADHD treatment. There are a variety of evidence-based pharmacological and 
nonpharmacological treatments for ADHD that vary in effectiveness, side effects, and perceived 
acceptability by children and their parents. Both the American Academy of Pediatrics (AAP) 
(Subcommittee on Attention-Deficit/Hyperactivity et al., 2011) and the American Academy of 
Child and Adolescent Psychiatry (AACAP) (Pliszka, 2007) recommend stimulant medication as a 
front-line intervention for children and adolescents with ADHD. Methylphenidate, amphetamine, 
and other stimulants mechanistically enhance the neurotransmission of dopamine and 
norepinephrine (Swanson & Volkow, 2002). In addition to the stimulant medications, several 
non-stimulant medications are also FDA-approved for treating ADHD in children and 
adolescents. Guanfacine, atomoxetine and clonidine are all non-stimulant medications that are 
used in pediatric ADHD management. Largely based upon the weaker effect sizes associated 
with non-stimulants (0.95 for stimulants and 0.62 for non-stimulants) (Faraone, 2003), both AAP 
and AACAP recommend that providers prescribe a stimulant before considering non-stimulants 
(Pliszka, 2007; Subcommittee on Attention-Deficit/Hyperactivity et al., 2011).  
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In popular culture and the media, stimulants are viewed as controversial due to the 
perceived possibility of tics, affect flattening, increased risk of substance abuse/misuse, and 
stunted growth, none of which have been empirically confirmed (Faraone, 2003). For example, 
despite fears of ADHD increasing the likelihood of a future substance use disorder, a meta-
analysis of longitudinal research on children with ADHD indicated that pharmacological 
treatments may actually reduce the risk for a substance-use disorder by 50% (Wilens, Faraone, 
Biederman, & Gunawardene, 2003). Furthermore, the development of long-acting stimulants has 
increased the ease of use for stimulants, with similar effectiveness and side-effects as the 
immediate release formulations, as well as decreased the potential for misuse/abuse (Biederman 
& Faraone, 2005). However, despite the effectiveness of stimulants, and for multitude of reasons, 
parents may opt to not engage in pharmacological treatments in favor of nonpharmacological 
treatments for their children. 
A meta-analysis of nonpharmacological treatments for ADHD indicated that some 
nonpharmacological treatments may be efficacious (Hodgson, Hutchinson, & Denson, 2014). 
Specifically, behavior modification (i.e., the use of reinforcement and punishment to shape 
behavior) and neurofeedback (i.e., training in controlling and decreasing theta wave activity and 
increasing beta wave activity as a means to enhance attention and concentration) were both 
supported as evidence-based nonpharmacological treatments for ADHD symptoms (Hodgson et 
al., 2014). Another meta-analysis indicated some empirical support for fatty acid 
supplementation and dietary restrictions for treating ADHD symptoms (Sonuga-Barke et al., 
2013). Support for other nonpharmacological treatments (e.g., behavioral parent training, 
working memory training) for targeting ADHD symptoms (not associated functional 
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impairments) is more mixed (Hoath & Sanders, 2002; Hodgson et al., 2014; Klingberg et al., 
2005).  
Although the Multimodal Treatment Algorithm (MTA) study indicated that stimulant 
medication is the most effective treatment for ADHD symptoms, adding behavioral treatments 
such as behavior modification may be of benefit for children who have ADHD and other 
comorbid conditions (Jensen et al., 2007). Despite the encouraging nonpharmacological data 
reviewed above, pharmacological treatment remains the most effective in treating core ADHD 
symptoms whereas nonpharmacological treatments may be useful as supplementary 
interventions for targeting functional impairments (Faraone, 2003). Thus, pharmacological 
treatments are generally considered to be a first-line treatment option for those with ADHD 
(Pliszka, 2007; Subcommittee on Attention-Deficit/Hyperactivity et al., 2011). 
Impact of ADHD treatment on outcomes. In a systematic review of long-term 
outcomes in ADHD, Shaw and colleagues (2012) identified nine major outcome domains that 
have been studied: 1) drug abuse/addictive behavior, 2) academic functioning (e.g., grade point 
average), 3) antisocial behavior, 4) social functioning, 5) occupational functioning, 6) self-
esteem (e.g., self-perception, suicidal ideation), 7) driving (e.g., automobile accidents), 8) service 
use (e.g., justice system, emergency health care), and 9) obesity. Individuals with untreated 
ADHD demonstrated poorer outcomes compared to non-ADHD participants in 74% of the 
outcome domains. Treated ADHD was associated with greater improvement compared to no 
treatment, improvement within-subjects as compared to baselines, and stabilization compared to 
baselines (i.e., no deterioration as seen in untreated ADHD). In addition, several studies included 
in Shaw and colleagues’ (2012) review found that over time (two to nine years) outcomes such 
as academic performance of participants with untreated ADHD decreased (Powers, Marks, 
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Miller, Newcorn, & Halperin, 2008; Schultz, Evans, & Serpell, 2009) and tobacco use increased 
(Whalen, Jamner, Henker, Gehricke, & King, 2003). Conversely, social outcomes in the treated 
ADHD group improved less robustly than other outcomes over eight years (Shaw et al., 2012). 
Overall though, Shaw and colleagues’ (2012) systematic review demonstrated that treatment of 
ADHD improves long-term outcomes, though typically not to the point of normalization of 
functioning (Ramos-Quiroga & Casas, 2011).  
ADHD Treatment Decision-Making 
 ADHD is a persistent and impairing disorder with negative long-term consequences. 
Evidence-based treatment during childhood and adolescence may decrease the impact of these 
consequences (Goksoyr & Nottestad, 2008; Shaw et al., 2012; Wilens et al., 2002). Despite the 
effectiveness of evidence-based treatments and the long-term negative impact of untreated 
ADHD, the NCS-R revealed that only 51.8% of people who meet criteria for ADHD will ever 
make treatment contact (Wang et al., 2005). Data from the National Epidemiologic Survey on 
Alcohol and Related Conditions reported a similar predicted treatment rate, 55% (Dakwar et al., 
2014). Additionally, the median delay from symptom onset to treatment for ADHD is estimated 
at 10.5 to 28 years with younger cohorts at the shorter end of the delay (Dakwar et al., 2014). 
Currently there is insufficient work fully explaining why only half of those with ADHD will ever 
be treated as well as why the significant delay to treatment that exists in ADHD.  
  Parents may be unsure of when or where to seek treatment for their child (Bussing, Zima, 
Gary, & Garvan, 2003). Likewise, over two thirds of parents with a child who meets criteria for 
ADHD do not see the need for professional treatment (Bussing et al., 2003). Children with more 
severe symptoms, males, Caucasians and parents who have social support are more likely to 
attempt to access treatment (Bussing et al., 2015; Bussing et al., 2003). Clearly, increasing access 
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to and engagement in evidence-based treatments for ADHD is a public health issue; services for 
ADHD should not be limited to Caucasian boys whose parents have high levels of social 
support; further investigation is needed.  
There are likely numerous and varied causes for the long delay to treatment and low rates 
of lifetime treatment engagement. Evidence from NCS-R indicates that the inability to recognize 
symptoms of a mental health disorder as well as attitudinal and evaluative barriers (e.g., low 
perceived credibility for treatments and presence of stigma respectively) are as significant or 
more significant than structural barriers (e.g., cost, transportation, etc.) in delaying or ceasing 
treatment (Mojtabai et al., 2011). Although structural barriers are significant, attitudinal and 
evaluative barriers are more important in predicting treatment initiation and continuation 
(Mojtabai et al., 2011). Understanding parental attitudes about ADHD treatment and how these 
attitudinal and evaluative barriers influence decision-making remains a topic that is less well 
understood.   
Parental symptom recognition and treatment decision-making. Parental recognition 
of symptoms or behavioral problems in their children is a strong predictor of accessing all types 
of services (Sayal, Goodman, & Ford, 2006). Nevertheless, although parents may be able to 
recognize the presence of ADHD symptoms, few access treatment for their children (Sayal et al., 
2006). Although general practitioner failure to recognize symptoms or behavioral problems may 
be a significant barrier to accessing evidence-based treatment, parents often characterize their 
children’s symptoms as behavioral, motivational or academic, rather than as inattention, and may 
not report it to their children’s treatment providers (Sayal et al., 2006). Not recognizing ADHD 
symptoms or attributing ADHD symptoms to an external cause may both lead to fewer parents 
accessing treatment for their children. 
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Parents play an additional role as gatekeepers to treatment and may elect to accept or 
deny access to evidence-based treatments for their children. Parents not only struggle in the 
decision to consent to a medication trial, but often revisit their decision (Brinkman et al., 2009). 
Parents report fears of the long-term negative effects of stimulants, even if their child has a 
positive response to the medication. Furthermore, parents report trial-stopping their children’s 
medication without approval from the prescribing doctor. Clearly, some parents are ambivalent 
about employing an evidence-based intervention for their children with ADHD, due to their 
concerns (Brinkman et al., 2009).  
Impact of stigma on treatment decision-making. Results from the National Stigma 
Study—Children (NSS-C) suggests that stigma may also play a role (Pescosolido, Fettes, Martin, 
Monahan, & McLeod, 2007; Pescosolido et al., 2008). NSS-C data indicated that the general 
public perceives children with ADHD to be more dangerous to themselves and others compared 
to children with asthma or “daily troubles” (Pescosolido et al., 2007). In addition, most people 
are unable to correctly identify symptoms of ADHD, and even when they do, they are unlikely to 
identify ADHD as a neurodevelopmental or mental health disorder, reflecting public perceptions 
that ADHD may not truly exist or be as severe as other mental health disorders (Pescosolido et 
al., 2007; Pescosolido et al., 2008). Results from the NSS-C also indicated that the general public 
places more blame and responsibility on parents of children with ADHD for their child’s ADHD 
compared to parents of children with depression and asthma (Mukolo & Heflinger, 2011).  
Parents of children with a mental health disorder may experience public or social stigma 
(Ahmed, Borst, Wei, & Aslani, 2013). Fear of stigma is the most commonly cited reason for not 
accessing mental health treatment (Gulliver, Griffiths, & Christensen, 2010). These concerns 
also exist for parents of a child with ADHD specifically (e.g., others questioning the existence of 
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ADHD, blaming the parent for the child’s misbehavior, concerns how others may view their 
electing to have their child on medication) (Bussing et al., 2012). The majority of parents of a 
child with ADHD (77%) report experiencing stigma, 44% report concern about how society 
might label their child, and 40% feel isolation and rejection because of their child’s ADHD 
diagnosis (DosReis, Barksdale, Sherman, Maloney, & Charach, 2010). Parents also report 
concerns about how diagnosis and treatment may affect their child’s future (e.g., low self-
esteem, decreased future success) (DosReis et al., 2010). Many parents of children with ADHD 
report that they experience stigma about their parenting practices from both family and the public 
(Ahmed et al., 2013). Likewise, mothers of children with ADHD expect parents of children 
without ADHD to have more negative views of children with ADHD (e.g., not being as bright as 
other children) even when the other parents do not endorse this view (Norvilitis, Scime, & Lee, 
2002). Fear of stigma is not only a barrier to accessing treatment, but is also a contributing factor 
to parents ceasing evidence-based pharmacological treatment for their children (Ahmed et al., 
2013; Kazdin, Holland, & Crowley, 1997).  
Parental fears of stigma towards themselves or their own children reduce the likelihood 
of accessing ADHD assessment and treatment services. However, although the public 
stigmatizes children with symptoms of ADHD more than children without ADHD symptoms, 
adding a diagnostic label is associated with only marginally higher rates of stigma (Ohan, Visser, 
Moss, & Allen, 2013). Thus, ADHD symptoms may be more stigmatizing than the label, 
“ADHD”. It may be beneficial to use this information when developing informational programs 
that aim to understand and increase treatment-seeking. For example, if parents understand that 
symptoms drive stigma more strongly than a diagnostic label, these parents may be more likely 
to seek treatment for their child. Overall, understanding what motivates parents to seek evidence-
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based treatment for their children should inform how the health professional fields interface with 
parents. 
Parental knowledge of and stigma towards ADHD treatment. A parent’s decision to 
engage in different types of treatment, or treatment at all, for their children once they have a 
diagnosis of ADHD, is related to numerous parental cognitive factors. Parents often make these 
decisions in times of stress without having taken time to become better informed of their options. 
For example, one study of public attitudes towards ADHD and ADHD treatment reported that 
78.3% of participants believe that too many children with a diagnosis of ADHD do not really 
have ADHD (e.g., are misdiagnosed) (Partridge, Lucke, & Hall, 2014). In addition, the public 
endorses the use of medication as less acceptable for ADHD than medication treatment for 
depression (Partridge, Lucke, & Hall, 2012; Partridge et al., 2014). These public perceptions are 
important to consider when examining the context within which parents make treatment 
decisions as these public views negatively affect ADHD medication treatment attitudes 
(Partridge et al., 2014). 
A portion of the negative attitudes about ADHD and associated evidenced-based 
treatments may be related to misconceptions and lack of knowledge about evidence-based 
interventions.  In general, people with higher levels of educational attainment are more likely to 
endorse medication as a viable treatment for both ADHD and depression (Partridge et al., 2012). 
Higher education levels may be associated with increased informational exposure and better 
understanding of medication as well as ADHD in general. Moreover, higher levels of 
misconceptions about ADHD treatment (e.g., taking stimulant medications in childhood leads to 
recreational drug abuse in the teenage years) and lower levels of knowledge about ADHD and 
evidence-based treatments are related to lower perceived acceptability of ADHD medications 
  
13
(Sciutto, 2015). Likewise, parental knowledge about ADHD is positively associated with 
medication acceptability, parental knowledge about ADHD is not related to counseling 
acceptability (Bennet, Power, Rostain, & Carr, 1996). Lack of knowledge about these treatments 
may lead a parent to endorse counseling over medication. Yet after learning more about 
medication treatment, these same parents might become more accepting of medication based on 
its better effectiveness and outcomes. Taken together, these results indicate that parental 
educational attainment and exposure to information about ADHD predict attitudes about ADHD 
medications.  
Consistent with these results, one study that examined the acceptability of 
methylphenidate and behavior modification for ADHD, found that parents of both children with 
and without ADHD viewed behavior modification as the most acceptable option, combined 
treatment as the second most acceptable, and medication as the least acceptable for treatment of 
their children (Liu, Robin, Brenner, & Eastman, 1991). However, after personal experiences with 
these interventions, the acceptability of combined treatment and medication significantly 
increased. This increase in acceptability was associated with an increase in knowledge, but not 
with an actual improvement in symptoms. Stroh, Frankenberger, Wood, and Pahl (2008) reported 
similar results in that parents of children with ADHD rated the effects of medication more 
positively than parents of children without ADHD. In addition, parents of children with ADHD 
rated the side effects of ADHD medications as less severe than parents of children without 
ADHD. These results suggest that increased understanding and personal positive experiences 
medication may lead to higher parental acceptability ratings. Therefore, it may be important to 
educate parents on both the benefits of medication and the risks of not utilizing medication, to 
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help parents understand why medication, even with possible side effects, may represent an 
important treatment consideration.  
Parental attitudes are also important due to their effect on actual treatment-seeking 
behaviors and subsequent treatment adherence. Positive parental attitudes towards the benefits of 
stimulant medications for ADHD predict later adherence to medication and perceived medication 
acceptability (Hebert, Polotskaia, Joober, & Grizenk, 2013). Parents are less willing to engage in 
both psychosocial and pharmacological treatments for their children if they do not feel 
knowledgeable about or endorse the acceptability of these treatments (Bussing et al., 2012). 
Unsurprisingly, willingness to engage in treatment for their children is positively related to 
parents’ views on the acceptability and helpfulness of treatment (Bussing et al., 2012). These 
results further support the importance of parental knowledge in predicting treatment-seeking and 
adherence behaviors.  
Parent self-efficacy and treatment decision-making. Parents’ attitudes about 
themselves in their parent role, termed parenting self-efficacy, is positively associated with 
perceptions of effectiveness for behavioral treatments for ADHD (Jiang, Gurm, & Johnston, 
2014). This may be due to the need for a high level of parental engagement in ADHD behavioral 
treatments (e.g., consistently apply reinforcement schedules). If parents feel more equipped to 
participate effectively in their child’s treatment, they may be more hopeful about the possible 
effectiveness of behavioral treatments that have increased parental demands.  
Another study examined mothers of children with ADHDs’ ratings of acceptability and 
effectiveness of psychosocial and stimulant medications for their own children and for children 
described in case vignettes (Johnston, Hommersen, & Seipp, 2008). Mothers rated behavioral 
training as more acceptable than medication and behavioral training and medications as equally 
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effective for a vignette child described as having ADHD. However, these same mothers rated 
medication as more effective than behavioral training for their own children, despite viewing 
behavioral interventions as more acceptable than medication. These findings suggest the 
presence of possible dissonance between views of acceptability and views of effectiveness of 
treatments. In addition, mothers’ previous experiences with behavioral interventions were 
positively associated with ratings of effectiveness of behavioral interventions. This is consistent 
with Jiang et al.’s (2014) findings and suggests that perceptions of ability to successfully 
participate in behavioral interventions are related to both preference for, and ratings of 
effectiveness for, these treatments.  
A third study examining parenting self-efficacy supported these conclusions. Johnston, 
Mah, and Regambal (2010) found that mothers with higher parenting self-efficacy believed that 
behavioral intervention was more likely to be effective. These beliefs predicted future positive 
treatment experiences. These data again implicate parenting self-efficacy as predictive of 
experiences and success of behavioral treatments and highlight the need to understand the 
specific variables in a family that may inform treatment success.  
Child impairment is positively associated with mothers’ ratings of the acceptability and 
effectiveness of combined treatment for a hypothetical child with ADHD (Jiang et al., 2014). 
Furthermore, when mothers viewed their own child’s ADHD symptoms as more pervasive and 
within their child’s control, they rated behavioral treatment as more acceptable. Parents actual 
experiences and successes when implementing these techniques, however, were unrelated to 
their perceptions of their child’s symptoms (Johnston et al., 2010). Moreover, parents’ perception 
of actual symptoms may affect what types of treatment they endorse. For example, parents’ 
endorsements of their children’s externalizing symptoms are related to acceptability of 
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counseling therapy, but not medication use (Bennet et al., 1996). Parents who perceive their child 
as more oppositional and aggressive are more likely to pursue counseling, but not medication, as 
compared to parents who do not perceive their child’s symptoms to be externalizing in nature. 
These findings indicate that parental perceptions of child symptoms may influence and increase 
treatment-seeking, but this effect is not consistent for all treatment types.  
In addition to parent attitudes towards, and knowledge of, ADHD treatments, 
relationships with providers have also been demonstrated to be a significant predictor of 
treatment decision making for parents of children with ADHD.   
The patient-doctor relationship. Children’s access to treatment is complicated to the 
extent that they are developing within an bioecological (also referred to as ecological or social-
ecological) model comprised of microsystems (i.e., immediate environments such as school and 
family), mesosystems (i.e., links and relations between microsystems), exosystems (i.e., links 
between microsystems and outside environments such as the link between home and the parents’ 
workplaces), macrosystems (i.e., patterns of various systems and cultures surrounding the child), 
and chronosystems (i.e., change over time in the various ecosystems of the child) 
(Bronfenbrenner, 1994; Tudge, Mokrova, Hatfield, & Karnik, 2009).  
Broadly, the bioecological model can be applied to this treatment-seeking paradigm. As 
highlighted, parents represent a critical component of a child’s bioecological system, but they are 
not the only influential component of treatment access. Part of both parents’ and children’s 
bioecological system is the treatment provider. Given that three quarters of children and 
adolescents with psychiatric disorders are treated by primary care physicians (Martini et al., 
2012), primary care physicians also represent gatekeepers to evidence-based treatments. 
Pediatric primary care physicians act as facilitators of knowledge about ADHD symptom 
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recognition and knowledge / access to evidence-based treatment (Stiffman, Pescosolido, & 
Cabassa, 2004). 
One critical relationship in the child’s exosystem that can affect parents’ treatment 
attitudes and knowledge is the relationship between past medical providers and parents (Coletti 
et al., 2012; Ha & Longnecker, 2010; Kraetschmer, Sharpe, Urowitz, & Deber, 2004; Vermeire, 
Hearnshaw, Van Royen, & Denekens, 2001). Parents of children with ADHD prefer treatment 
providers who are diagnostically expert, provide ample and varied psychoeducation, and explain 
ADHD using a chronic illness metaphor (Coletti et al., 2012), consistent with research in the 
general health field that patients want doctors who are both diagnostically competent and can 
communicate effectively (Ha & Longnecker, 2010). Further, more concern about physician 
communication is raised than concerns about clinical competency (Ha & Longnecker, 2010). 
There are a variety of downstream effects from the patient-doctor relationship, such as 
reinforcing patient self-confidence, motivation, and hopefulness regarding treatment outcomes 
(Ha & Longnecker, 2010). In addition, patients prefer shared decision-making with their doctors, 
and those who engage in shared decision-making have high levels of trust in their doctors 
(Kraetschmer et al., 2004). Active shared decision-making and high quality patient-doctor 
relationship are associated with adherence to medication (Vermeire et al., 2001). Thus, patient-
doctor relationships have the potential to affect decisions that parents choose to make regarding 
their child’s treatment. 
Parental, especially maternal, psychiatric disorders are a risk factor for ADHD 
(Biederman, Faraone, & Monuteaux, 2002; Biederman et al., 1995). This variable, however, has 
not been studied towards predicting treatment-seeking for their child. However, personal 
experiences and success with ADHD medication increases positive ratings of future medication 
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treatment (Liu et al., 1991). Thus, examining how a parent’s relationship with their own provider 
may might treatment decision making for their child likely represents a novel way to consider 
parental treatment decision making. The current study aims to investigate this topic.  
Summary / Need for Current Study 
Childhood ADHD is characterized by high prevalence, functional impairment, likelihood 
of psychiatric comorbidities and negative long-term consequences, a heterogeneous etiology, and 
a significant economic burden on the health care system rendering it a topic of significant public 
health import (Akinbami et al., 2011; Biederman & Faraone, 2002, 2005; Birnbaum et al., 2005; 
R.C. Kessler et al., 2005b; Killeen et al., 2012; Lahey et al., 1994; Schipper et al., 2015). 
However, despite (a) the considerable public health problem represented by ADHD, (b) the 
availability and evidence base for effective treatments (e.g., stimulant medications) (Faraone, 
2003), and (c) negative long-term impacts of untreated ADHD (Shaw et al., 2012), there is still a 
significant delay to treatment as well as low rate of lifetime treatment contact in the ADHD 
population (Dakwar et al., 2014; Wang et al., 2005). 
The factors that influence the (lack of) treatment-seeking are copious and diverse. Poor 
symptom recognition, attitudinal barriers, and evaluative barriers are just as, or more significant 
barriers to treatment than structural barriers (Mojtabai et al., 2011). The general public does not 
label ADHD symptoms as characteristic of a clinical disorder (Bussing et al., 2003; Pescosolido 
et al., 2007). Parents of children with ADHD may fear public stigma about themselves or their 
children as well as harbor personal stigma about ADHD and its evidence-based treatments 
(Ahmed et al., 2013; Bussing et al., 2012; DosReis et al., 2010). These fears and attitudes as well 
as a lack of knowledge about treatments such as stimulants may lead to decreased acceptability 
ratings of medication for ADHD (Partridge et al., 2012, 2014; Sciutto, 2015). Additionally, 
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perception of childhood symptoms (e.g., externalizing vs. internalizing) as well as their own self-
perceived parenting effectiveness affects what types of treatment parents prefer (Bennet et al., 
1996). Finally, previous patient-doctor relationships also affect treatment decision-making 
(Coletti et al., 2012; Ha & Longnecker, 2010; Kraetschmer et al., 2004; Vermeire et al., 2001).  
Much of the previous research reviewed above has used case vignettes and hypothetical 
children in the research design. As suggested by Jiang and colleagues (2014), however, there 
may be a difference between parental attitudes towards treatment for a hypothetical child 
compared to views for their own children. Thus, research that focuses only on hypothetical 
scenarios may be limited in revealing what barriers are actually most significant to treatment-
seeking. In addition to increased ecological validity, there is reason to investigate parental 
attitudes about treatment in reference to their own children without an ADHD diagnosis (i.e., 
non-treatment-seeking). The goal of this line of research is to determine how parents’ views of 
treatment may vary for their own children compared to their views for someone else’s child in 
the context of their child’s own symptoms (or lack of symptoms).   
The current study will focus on non-treatment-seeking parents. Treatment decision 
making studies have historically focused on attitudes towards case vignettes and hypothetical 
children or parents whose children are being assessed for, or already have, a diagnosis of ADHD 
(i.e., parents that have already made the decision to seek professional help). Mental health 
treatments only work for those who access them. To the extent that research on treatment-
seeking attitudes is limited to these currently examined samples, the reasons that parents who 
might need, but do not seek, treatment for their own child with ADHD remain unexamined. 
Parents who have made treatment contact for their child have overcome barriers to treatment and 
may differ from those who do not make treatment contact for their child.  
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Given the high delay from symptom onset to treatment that exists ADHD (Dakwar et al., 
2014), this is a significant issue to further study.  Understanding the trajectory of treatment-
seeking attitudes and behaviors in a sample who has not yet sought treatment can help to further 
extend our understanding of treatment decision-making. Although the existing research base has 
provided significant and important information for beginning to understand why parents delay 
treatment for their children’s ADHD, the crucial next step is to understand what separates those 
who have overcome barriers to seek treatment and those who have not yet pursued treatment. 
The current study aims to investigate what barriers are most salient in this understudied sample 
in their relation to treatment-related attitudes.  
Furthermore, the majority of studies have asked participants to rate the acceptability and 
effectiveness of interventions, which although certainly related, may over estimate actual 
treatment-seeking behaviors. For example, although psychological models of behavior often cite 
attitudes as the best predictor of someone’s behavior, intentions and attitudes only account for 
approximately 28% of the variance in predicting behavior (Sheeran, 2002). This is a significant 
portion, and thus attitudes and intentions should be valued when attempting to investigate 
treatment-seeking behaviors. However, attitudes and intentions alone are limited in their ability 
to completely predict behavior, and it may be insufficient to examine attitudes and intentions in 
isolation, especially in a non-treatment-seeking sample that has not initiated any treatment 
behavior. 
There are several ways that this problem may be addressed. Future research could 
distinguish treatment-seeking intent (e.g., “I would ask my doctor for medication.”) versus 
treatment-seeking behavior (e.g., “Medication is safe for use.”). However, since intentions and 
attitudes are, in isolation, limited in predicting behavior (Sheeran, 2002), behavioral measures of 
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actual treatment-seeking (e.g., seeking out more information, making an appointment for their 
child) may provide different and potentially more informative data about treatment decision 
making. To the extent that parents serve as gatekeepers to treatment for their children, their 
attitudes, opinions, and actual behaviors are each important towards informing intervention 
developments aimed at increasing treatment access for children with ADHD. By increasing 
treatment access, the ultimate goal of reducing the long-term negative outcomes associated with 
ADHD may be realized.  
 The current study aims to investigate previously identified factors in parents of children 
with ADHD and how these factors relates to not only treatment attitudes but also information-
seeking behaviors in a sample of parents whose children have not been diagnosed with ADHD. 
A majority of parents of a child with ADHD use the Internet to find information about ADHD 
and its treatments (Sage et al., 2017). However, little has been done to examine the factors 
associated with this information-seeking behavior. Parents’ ability to recognize ADHD 
symptoms as characteristic of the disorder, parenting-self-efficacy, parent ratings of satisfactions 
with past providers for themselves and their children, beliefs about the causal attributions of 
ADHD, knowledge about ADHD and ADHD treatments, and stigma towards ADHD will be 
examined as predictors towards parents’ treatment attitudes and information-seeking behavior.  
To our knowledge, this is the first study that will examine these factors together as well 
as their relation to a measure of information-seeking behavior, rather than attitudes alone. 
Understanding what factors influence behaviors, not only attitudes, is important because 
someone may not hold strong negative attitudes towards treatment, but, for a variety of reasons, 
not actually seek treatment. Further, efforts to decrease barriers to mental health treatments have 
historically included information campaigns (Perry et al., 2014; Pinfold et al., 2003; Schachter et 
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al., 2008; Spence et al., 2005; Watson et al., 2004; Wyn, Cahill, Holdsworth, Rowling, & 
Carson, 2000). To the extent that we do not understand factors that affect information-seeking 
and-acceptance in those that have not yet considered treatment (but may in the future), the utility 
of these programs is unclear. Moreover, without the understanding of the factors that affect 
behaviors, efforts to increase treatment-seeking are limited. If we wish to affect behavior, we 
must study behavior.  
Hypotheses 
Based upon the research cited above in the literature on general attitudes (e.g., case 
vignettes, not about their own child) and treatment-seeking parents of children with ADHD, the 
following hypotheses will be tested in a non-treatment-seeking sample (See Figure 1).  
Hypothesis 1a: Perceptions of ADHD symptoms as externally controlled, high parenting 
self-efficacy, high stigma about ADHD, and high misconceptions about ADHD will be 
significantly associated with more negative attitudes about ADHD medication (Bennet et al., 
1996; Jiang et al., 2014; Johnston et al., 2008).  
 Hypothesis 1b:  Personal experiences and success with ADHD medication increases 
positive ratings of future medication treatment (Liu et al., 1991). Parents prefer collaborative 
relationships with treatment providers (Coletti et al., 2012; Ha & Longnecker, 2010; 
Kraetschmer et al., 2004; Vermeire et al., 2001). Based upon both, it is hypothesized that greater 
parent satisfaction with treatment providers for themselves or their children will be significantly 
associated with positive ADHD treatment attitudes.  
Hypothesis 1c: Ability to recognize symptoms of ADHD correctly and knowledge about 
ADHD will be significantly associated with positive attitudes toward ADHD treatments, 
consistent with previous research (Bennet et al., 1996; Sciutto, 2015). 
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Hypothesis 2a: There is currently no research that has examined information-seeking 
behavior. Thus, these hypotheses are necessarily exploratory. However, we hypothesize that, 
consistent with Hypothesis 1a, high misconceptions about ADHD treatments and high stigma 
will be negatively associated with information-seeking behavior. Given that parenting self-
efficacy and perceptions of ADHD of externally controlled and impairing are positively 
associations with behavioral treatments (Jiang et al., 2014; Johnston et al., 2008), we hypothesize 
that these variables will be positively associated with ADHD information-seeking behavior.  
Hypothesis 2b: Consistent with Hypothesis 1b, greater satisfaction with treatment 
providers for themselves or their children will be significantly and positively associated with 
ADHD information-seeking behavior.  
Hypothesis 2c: Consistent with Hypothesis 1c, ability to recognize symptoms of ADHD 
and knowledge about ADHD and evidence-based treatment will be significantly and positively 
associated with ADHD information-seeking behavior.  
Hypothesis 3: Finally, since attitudes and intentions are significant predictors of behavior 
(Sheeran, 2002), treatment attitudes are hypothesized to be significantly and positively 
associated with the behavioral measure of treatment/information-seeking. However, this 
association will likely be moderate in strength as non-treatment-seeking parents may report 
positive attitudes, but do not actually intend on seeking more information about treatment.  
Methods 
Participants 
 Participants were recruited from two sites: (a) a traditional, inclusive summer camp of 
approximately 1000 campers in the Northeastern United States and (b) Amazon’s Mechanical 
Turk (mTurk). The purpose of using two ascertainment sites was to increase the diversity and 
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representativeness of the sample. The final sample included in analyses was 169 parents (n=36 
from the summer camp; n=133 from mTurk). 
Parents recruited from the summer camp (1) were English speaking and (2) had a child 
enrolled in the summer camp. All parents of campers from the summer camp were invited to 
participate. Of the 51 participants who initially consented to the study, 43 (84.3%) completed at 
least half of the survey. Of these 43 participants, 7 had children with ADHD (16.3% of camp 
sample) and thus were excluded from the sample (final sample n=36). The camp sample was 
2.8% men and 100% White. The mean age of the parents was 42.44 years (SD=6.93), and 92.2% 
had completed some college or more. These demographic data are consistent with those reported 
in previous studies conducted at the same summer camp (Kingery, Peneston, Rice, & Wormuth, 
2012). 
 Amazon’s mTurk is an online platform in which potential research participants can 
access a variety of research studies referred to as “Human Intelligence Tasks” (HITs). 
Participants select HITs of interest and are paid for their time (Behrend, Sharek, Meade, & 
Wiebe, 2011). Participant data derived from mTurk data demonstrates equivalent or higher 
psychometric quality as data from published research using both traditional and other web-based 
samples, including representing more diverse populations than typical internet-based and college 
samples (Behrend et al., 2011; Buhrmester, Kwang, & Gosling, 2011; Shapiro, Chandler, & 
Mueller, 2013). In mTurk, researchers either approve or disapprove of a worker's HIT once it has 
been completed. This increases participant motivation to complete HITs. Workers are also 
prevented from changing reported demographic characteristics to complete studies with 
demographic requirements.   
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To be eligible to participate, mTurk participants had to: (1) reside in the U.S. and (2) 
have completed at least 95% of their previous HITs successfully. A third inclusion criteria (3) be 
a parent, was added for this study. All 152 mTurk participants completed the entire survey. 
Nineteen participants identified that they had a child with ADHD (12.5% of mTurk sample) and 
were thus dropped from the analyses (final mTurk sample n = 133). The sample was 33.1% men 
and 91% White. The mean age was 39.41 years (SD = 9.62), and 82.7% had completed some 
college or more. These demographic characteristics are comparable to those reported in previous 
mTurk samples (Behrend et al., 2011).  
As the current study aimed to examine non-treatment-seeking individuals, participants 
whose child had ADHD were excluded from analyses (n=26; final sample n = 169). Chi square 
analyses indicated no significant site differences on percentage of children with ADHD (X2(1) = 
0.55; p = .46).  
After the two sites were combined, the omnibus sample (n = 169) was 26.6% men and 
92.9% White. The mean age was 40.00 years (SD = 9.22), and 85.8% had completed some 
college or more. Participants who were missing more than half of their data points (n = 8; all 
from the camp site) were excluded from analyses. On remaining data, mean series multiple 
imputations were conducted to replace missing values for data that was non-demographic and 
scalar in accordance with recommendations for handling missing data (Raaijmakers, 1999).  
ADHD symptoms and impairment ratings. Despite being non-treatment-seeking, child 
ADHD symptoms (See Table 1) indicated that parents reported elevated total ADHD, 
hyperactivity-impulsivity, and inattention symptoms in their children based on gender- and age- 
normed scores (70.76th, 72.83rd, 68.26th percentiles, respectively) (DuPaul, Power, Anastopoulos, 
& Reid, 2016). Additionally 69 parents (40.8%) reported that their children’s global impairment 
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rating was in the clinically significant impairment range (Fabiano et al., 2006). Time spent on 
ADHD information page was not associated with parents’ rating of child impairment (r = .10, p 
= .20), however, it was marginally related to ADHD-RS-5 total symptoms (r = .15, p = .05). No 
significant differences in child symptoms emerged between those who sought additional more 
information about ADHD resources and those who did not (F(1,157) = 1.11, p = .29; η2 = .01. 
However, parent rated child functional impairment was higher for those who sought additional 
information about ADHD resources (F(1,157) = 12.56, p = .001; η2 = .07; sought more 
information M=2.92; SD=1.97; did not seek more information M = 1.48; SD = 1.61). 
Procedure 
All campers were given a letter for their parents explaining the study and inviting the 
parents to go to a Qualtrics link if interested. The study was also advertised on parents’ 
electronic camp registration account. Parent participants from the summer camp were 
compensated by entrance into a weekly raffle for a $100 gift card. Chances of selection were 
approximately 1 in 7. Parents from the summer camp received a link to be entered into the raffle 
at the end of the Qualtrics survey. The study was also advertised on mTurk’s HIT homepage. All 
mTurk parent participants were compensated with a $1 credit to their mTurk account, which is in 
compliance with mTurk standards (Buhrmester et al., 2011). 
Informed consent was presented at the beginning of the survey where participating 
parents either accepted or declined to participate (97.1% accepted). Parents completed all 
measures on Qualtrics. The duration of the study protocol was approximately 25 minutes (range: 
11 – 60 minutes). Two validity checks (e.g., “The answer to the following question is blue”) 
were embedded in the survey to assess for attentiveness. All 169 participants correctly answered 
both validity checks.  
  
27
Measures 
Demographic / Parent self-report of symptoms. Demographic data was collected on 
parent race, gender, ethnicity, education level, age, past and current mental health diagnoses, past 
and current medication use, ratings of satisfaction with past treatment providers, marital status, 
and number of children. Parents were asked to provide demographic data for their child with the 
“most challenging behavior” and use this target child when completing study measures (e.g., 
ADHD symptom ratings, etc.). Information was collected on that child’s gender, age, grade 
level, past and current mental illness diagnoses, ADHD symptoms and functional impairment 
ratings, past and current medication use and parent ratings of satisfaction with past child 
treatment providers. Ratings of satisfaction with past treatment providers, for both self and child, 
were assessed with the questions, “What has been your experience with your [child’s] treatment 
providers?” rated on a 5-point Likert scale from “extremely dissatisfied” to “extremely 
satisfied.” 
Patient Health Questionnaire (PHQ-4). The PHQ-4 is a 4-item brief screening tool that 
measures symptoms of anxiety and depression (Kroenke, Spitzer, Williams, & Löwe, 2009). 
High scores on the PHQ-4 are associated with higher levels of internalizing symptoms. The 
PHQ-4 has good construct validity and internal consistency (α  > .80) (Kroenke et al., 2009). In 
the current sample the PHQ-4 demonstrated good internal consistency  (α  = .87). Parents 
completed the PHQ-4 about themselves.  
Adult ADHD Self-Report Scale (ASRS) Screener. The ASRS screener is a six-item 
measure generated from symptoms of ADHD in adults (Kessler et al., 2005a). The items 
represent DSM-IV criteria and can be divided into 4 inattentive symptoms and 2 hyperactive-
impulsive symptoms. Scores range from 0 to 24 where higher scores indicate higher levels of 
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symptoms of ADHD. The screener demonstrates high sensitivity (68.7% accurate), specificity 
(99.5% accurate), and total classification accuracy (97.9%) in examining adults with and without 
ADHD. In the current sample internal consistency was good  (α  = .84). Parents completed the 
ASRS about themselves.  
Symptom recognition. 
Clinical Vignettes. Vignettes with a precedence in the child stigma literature (Jorm, 
Wright, & Morgan, 2007; O’Driscoll, Heary, Hennessy, & McKeague, 2012) were adapted to 
depict a child with ADHD, social anxiety disorder,  and “daily troubles.” An additional control 
vignette characterizing asthma was added (Burns, 2013). Social anxiety disorder was selected as 
a comparison vignette as previous research suggests that symptom recognition is low for this 
condition (Coles et al., 2016). Diagnostic labels were not used within the vignettes. 
 Two questions followed each clinical vignette to assess perceptions of whether the case 
vignette symptoms warranted professional treatment. First, participants responded to the prompt 
“[NAME] has a problem that needs professional help” using a 1-9 Likert scale where 1 is 
"strongly disagree" and 9 is "strongly agree." Next, the open-ended question "What do you think 
is going on with [NAME]?" assessed participants’ ability to accurately label symptoms of the 4 
conditions (ADHD, social anxiety, asthma, “daily troubles”). Codes were replicated from a 
previous study that used this methodology (i.e., 0 = no mental illness label, 1 = vague mental 
illness label, 2 = correct mental illness label; see Taylor, Ponzini, & Schofield, unpublished 
manuscript for more information). All responses were coded by two independent raters blinded 
to the hypotheses of the study (IRR > 84.04%). All discrepant codes were discussed among 
independent raters and the first author until consensus was reached.  
Mental Health Stigma. 
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Attention Deficit Hyperactivity Disorder (ADHD) Stigma Questionnaire (ASQ).  The 
ASQ is a 26-item questionnaire used to assess public stigma towards ADHD (Kellison, Bussing, 
Bell, & Garvan, 2010). There are three distinct subscales: Disclosure Concerns (e. g., “People 
with ADHD work hard to keep it a secret”), Negative Self-Image (e. g., “People with ADHD feel 
ashamed of having ADHD”) and Concerns with Public Attitudes (e.g., “People with ADHD are 
treated like outcasts”). The current measure was adapted slightly from the original ASQ to 
address parents’ beliefs about their children (e.g., “If my child had ADHD, we would work hard 
to keep it a secret”). The ASQ is measured on a 4-point Likert scale (1 is strongly disagree and 4 
strongly agree) with higher scores indicating higher public stigma. The original ASQ has good 
internal consistency (α = 0.93), test-retest reliability (ICC = .71), and convergent/divergent 
validity (Kellison et al., 2010). The adapted ASQ demonstrated good internal consistency in this 
sample (α = .97), at levels consistent with previous research (Kellison et al., 2010). A Pearson 
correlation between the attribution questionnaire (Corrigan, 2008) stigma score for ADHD and 
the ASQ was computed to determine convergent validity. There was a significant correlation 
between the ASQ and the AQ-9 (r = .40, p < .001). Thus, the adapted ASQ demonstrates solid 
psychometric properties.  
Attribution Questionnaire (AQ-9). General stigma was measured with an adapted 
version of the 9-item AQ-9 (Corrigan, 2008). The AQ-9 measures self-reported levels of stigma 
towards someone who has a mental illness. Each item is rated on a 1 – 9 Likert scale. 
Participants read the 4 clinical vignettes (Jorm et al., 2007; O’Driscoll et al., 2012) described 
above. Following each vignette, AQ-9 questions were rephrased to address the subject of the 
vignette and assess stigma (e.g., anger toward the individual, perceived dangerousness). An 
average stigma attitude score was calculated across the AQ-9 questions for each of the 4 
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vignettes to create an overall assessment of stigma attitudes towards a particular disorder, a 
strategy that has precedence in the literature (Pinto, Hickman, Logsdon, & Burant, 2012). In the 
current sample internal consistency was poor for social anxiety disorder  (α  = .56), ADHD (α  = 
.58), and asthma (α  = .59), and acceptable for daily troubles (α  = .70). This measure was used 
solely to validate the ASQ.  
Causal Attributions Scale. Causal beliefs about the 4 vignette characters (ADHD, 
asthma, social anxiety disorder, and daily troubles) were measured with the Causal Attribution 
Scale (Martin, Pescosolido, & Tuch, 2000). The Causal Attribution Scale is a six-item 
questionnaire that assesses whether participants believe the cause of a problem is medical/genetic 
(e.g., vignette characters’ “parent or other members of family have the same condition”), social 
(e.g., vignette characters’ “parents did not raise him/her right”), or moral/individual (e.g., 
Vignette character “is not trying hard enough to get better”). Participants were asked “If any of 
these things could be a part of the vignette characters’ condition?” using a 7-point Likert scale 
whereas 1 represents “not at all true” and 7 represents “very true.”  In the current sample internal 
consistency was poor for social anxiety disorder  (α  = .58) and ADHD (α  = .51), questionable 
for asthma (α  = .65), and good for daily troubles (α  = .84). 
 Three items (“[his] parents did not raise him right” indicating upbringing, “[he] is not 
trying hard enough to get better” indicating effort, and “[he] has experienced more stressful 
events in his life than most people do” indicating environmental stress) were significantly 
correlated (all rs>.37, all ps<.001) and thus were combined to create a scale of external / non-
biological causal attributions in an effort to reduce Type I errors. In the current sample internal 
consistency was questionable (α  = .63). Endorsement of external / non-biological causes of 
ADHD are important to understand to the extent that they represent a common parental 
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misunderstanding of ADHD diagnosis and treatment (Bussing et al., 2012; Pescosolido et al., 
2007; Pescosolido et al., 2008). 
 Knowledge and Misconceptions.  
 Strength of Belief in ADHD Knowledge Scale (SBAKS). The SBAKS is a 26-item 
true/false scale that measures participants’ knowledge and misconceptions of ADHD treatments 
(Sciutto, 2015). This measure assesses both participants’ knowledge and misconceptions about 
ADHD treatments and confidence in their answers. Confidence is rated on a 4-point Likert scale 
from 0 (i.e., just a guess) to 3 (e.g., I am certain). Internal consistency in ADHD knowledge and 
confidence was questionable to excellent (all αs > 0.60) in the current sample. A Pearson 
correlation between another test of mental health knowledge, the Knowledge of Mental Health 
Test (KHMT) (see below) (Taylor, Ponzini, & Schofield, Unpublished Manuscript) and the 
knowledge aspect of the SBAKS supported convergent validity (r=.35, p<.001). 
The Knowledge of Mental Health Test (KHMT). The KMHT is an achievement test that 
includes 17 questions; 8 multiple choice and 9 true/false. As expected based on guessing that 
occurs during an achievement test when participants have less information about a topic, overall 
internal consistency is poor (α = .51) yet acceptable in more knowledgeable participants (α = .74) 
(Taylor et al., Unpublished Manuscript). KMHT test-retest reliability is strong (r = .86, p<.001). 
The KMHT was used solely to demonstrate convergent validity with the SBAKS. Internal 
consistency in the current sample was consistent with previous research (α = .56). 
Parenting Self-Efficacy.  
 Parenting Self -Efficacy Scale. The Parenting Self-Efficacy Scale is a 25-item Likert 
scale (1 = not at all confident to 6 = very confident) that addresses parents’ confidence in their 
own parenting abilities (i.e., supporting child’s development and teaching their child age-
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appropriate tasks) (Suzuki, Holloway, Yamamoto, & Mindnich, 2009). Reported internal 
consistency was excellent (α = .92). Internal consistency in the current sample was similar (α = 
.94). The measure was derived using panels of developmental experts (e.g., developmental 
researchers, teachers, parent education specialists) and all items were rated as important to 
parenting by a sample of parents across multicultural contexts (Suzuki et al., 2009). One item 
(i.e., teach your child to learn the alphabet) was changed to (i.e., teach your child information 
needed for school) to be more appropriate for a variety of ages.  
Child ADHD Symptoms and Impairment. 
ADHD Rating Scale - 5th Edition (ADHD-RS-5). The ADHD-RS-5 is an 18-item rating 
scale based on DSM-5 criteria for ADHD, consisting of inattention and hyperactivity-impulsivity 
subscales (DuPaul et al., 2016). Internal consistency (α = .89 to .96) and test-retest reliability are 
good (rs=.80 to .87). Factor analyses support the two-domain structure. The scale also 
demonstrates strong concurrent validity with other measures of ADHD and good predictive 
validity (DuPaul et al., 2016). Internal consistency in the current sample was consistent with 
previous research (α = .95). 
Impairment Rating Scale (IRS). The IRS was developed for parents and teachers as a 
rating scale for severity of ADHD associated functional impairments (Fabiano et al., 2006). The 
IRS measures child impairment in the 8 areas of: peer, sibling, parent, and teacher relationships, 
academic, self-esteem, classroom/family, and global functioning. The IRS is stable over one year 
(r>.54 for parents) and reliable across informants (r=.78). It also demonstrates good concurrent, 
convergent, and discriminant validity. The IRS is effective in discriminating between children 
with and without ADHD (i.e., sensitivity above .65) (Fabiano et al., 2006). Given that the aims 
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of the current study did not focus on specific domains of child impairment, only the global 
impairment scale was examined. 
Treatment Attitudes.  
Questionnaire on Attitudes towards Treatment of ADHD (QATT). Attitudes towards 
common ADHD treatments were assessed using the parent report version of the QATT (Ferrin et 
al., 2012). The QATT is measured on a 5-point Likert scale, with 0 as “always false” and 4 
“always true.” The QATT measures three distinct categories of treatment attitudes: worries 
regarding treatment (5 questions), insight into illness and the need for medical treatment (5 
questions), and self-perception and patient–doctor relationship (3 questions). Worries regarding 
treatment are characterized by general worries, worries about the possible side effects of 
medication, beliefs that doctors over-prescribe, and belief that medication should only be used in 
extreme circumstances; higher scores indicate more worries about treatment. Insight is 
characterized by understanding the need for medical treatment, the importance of adhering to 
treatment as prescribed, and motivation to follow treatment plans; higher scores indicate more 
insight about treatment. Self-perception and the patient-doctor relationship is associated with 
contentedness with self and relationship with one’s doctor, higher scores indicate better self-
perception and patient-doctor relationship. The internal consistency is adequate (α > .66) for the 
first two subscales, but weaker (α = .58) for the self-perception and patient–doctor relationship 
factor. Internal consistency in the current sample was comparable (α = .65; .76; .55, 
respectively). Convergent validity with measures of treatment adherence is high (Ferrin et al., 
2012).   
Treatment-Seeking Behavior. 
 Information-Seeking Measure. At the end of the survey, participants were presented 
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with a mock webpage containing accurate information about ADHD and ADHD treatments. 
Time spent on this page was recorded via Qualtrics. Participants were then provided with the 
option to seek additional information about local community resources for ADHD assessment 
and treatment by clicking “yes I would like more information.” Decisions were recorded and 
dichotomized into sought additional information / did not seek additional information.  
Preliminary Analyses 
 Analyses were conducted in SPSS-24. Power analyses were conducted in G*Power. 
 Power analyses. A priori power estimates using effect sizes from previous research 
examining predictive factors (e.g., knowledge and perceptions of symptoms) of treatment-
seeking (Bennet et al., 1996; Sciutto, 2015) were calculated using G*Power. Assuming 80% 
power to detect significant associations, an alpha level of .05, a moderate effect size (f2 = .10), 
and two predictors, a sample size of 100 participants was needed to attain adequate statistical 
power. Using the same parameters, except with four predictors (consistent with Hypothesis 3), a 
sample size of 125 was needed to attain adequate statistical power. Thus, our study was 
adequately powered. 
Data inspection. Before conducting analyses, as suggested by Tabachnick and Fidell 
(2007), outlier data points were truncated to 3 SDs above/below the group mean of each 
measure. This practice helps to remove measurement error (Costa, 2014), allowing for variables 
to be changed to less extreme, but still high values. This truncation reduced the ability of an 
outlier to unduly influence statistical significance through Type I or Type II errors. A total of 
eight data points were truncated to 3SDs within the group mean. Notably, analyses including and 
excluding outliers were comparable. In this way, the analyses were not influenced by any 
influential cases.   
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Multicollinearity and normality assessment. Multicollinearity may increase the 
variance of the regression coefficients and result in a lack of statistical significance when the 
individual predictor is, in fact, significant (Type II Error), thus leading to inaccurate conclusions. 
Before testing hypotheses, multicollinearity was assessed through examination of the correlation 
matrix between variables within each hypothesis (see Table 2). A correlation coefficient of .80 
was used as a cutoff, as a strong correlation suggests that the variables are measuring the 
same/very similar constructs (Tabachnick & Fidell, 2007). In addition, during hypothesis testing, 
multicollinearity diagnostics were also conducted for each regression analysis using variance 
inflation factor (VIF). The VIF is an index of how much variance of a regression coefficient is 
increased due to multicollinearity and is a widely used method of detecting multicollinearity 
(Montgomery, Peck, & Vining, 2001). As suggested by previous research (Montgomery et al., 
2001), independent variables that have a VIF greater than 5 should be further investigated. Based 
on the correlation matrix (see Table 2) and VIF (reported in Tables 4 and 5), none of our models 
indicated need for concern about the effects of multicollinearity on results.  
In addition, the skewness and kurtosis of dependent and independent variables were 
calculated. As indicated by the parameter (e.g., +/-2) proposed by West, Finch, and Curran 
(1995), Time Spent on ADHD Information Page (skewness = 1.96, SE = .19; kurtosis = 3.84 SE 
= .38) and endorsements of ADHD as externally caused (skewness = 1.83, SE = .18; kurtosis = 
3.43, SE = .35) both violated the assumption of normal distribution. Therefore, these two 
variables were transformed using a logarithmic transformation so that each demonstrated a 
normal distribution (Osborne, 2005).  
Preliminary analysis of data collection sites. Chi square analyses and ANOVAs using 
weighted means to correct for unequal sample sizes were conducted to assess for ascertainment 
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site differences. Results indicated significant differences between recruitment site on several 
variables (See Table 1). Significant differences were detected in parent gender (X2(1) = 13.32; p 
< .001), parent education level (X2(1) = 5.03; p < .01, parent symptoms of depression (F(1,282) 
= 3.89, p = .05; η2 = .01), parent ratings of satisfaction with previous treatment providers 
(F(1,291) = 8.55, p = .004; η2 = .03), and ratings of satisfaction with child’s previous treatment 
providers (F(1,291) = 6.95, p = .01; η2 =. 02). The mTurk sample demonstrated slightly higher 
mean levels of depression, completed fewer years of formal education, included more males, and 
were less satisfied with both parent and child treatment providers than the camp sample. No 
significant effects of site emerged on other demographic or independent variables or any study 
dependent variables (all ps > .08). Further, inspection of the interaction terms indicated no 
moderation effects of site (all ps > .06), except for the interaction between Susceptibility to 
ADHD Stigma and site for insight into the need for treatment (r2  = .06, F(2,166) = 4.92, p =.01). 
However, Susceptibility to ADHD Stigma was not significantly associated with insight into need 
for treatment (r2  = .02, F(1,167) = 3.06, p =.08). Thus although site may have been a possible 
moderator, this non-significant relation was not explored in hypothesis testing.  
Nonetheless, given the site differences on an independent variable (provider satisfaction) 
and the significant interaction (Susceptibility to ADHD Stigma), site was added as the first step 
in the regression in analyses for all hypotheses. However, adding site into the model did not 
change the direction or significance of relations. As site was not associated with any dependent 
variables and adding site into the model did not change the direction or significance of relations, 
results are presented without site controlled to enhance power to detect significant associations. 
Given non-significant results for effects of site for other analyses, site was not controlled for in 
any of our other analyses. See Table 1 for all demographic data organized by site.  
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Preliminary analysis of demographic comparisons. ANOVAs and chi square analyses 
for parent gender using weighted means to correct for unequal sample sizes were also conducted 
on all dependent variables to assess for potential significant differences. Women spent more time 
on the ADHD information page (F(1,291) = 11.67, p = .001; η2 = .04) and held more positive 
total treatment attitudes (F(1,291) = 7.52 p = .01; η2 = .03). Thus, gender was included as a step 
in hypothesis testing models. Notably, similar to adding site to models, adding gender in the 
regressions did not change the direction or significance of relations, so results are presented 
without gender as a step to retain power to detect significant associations. No other significant 
gender differences were found for any dependent variables (all ps > .10). 
Between subjects ANOVAs and chi square analyses were conducted between child 
gender and all dependent variables to assess for significant differences. No significant gender 
differences were found on any dependent variable (all ps > .07). Therefore, child gender was not 
included in any further analyses.  
Pearson’s bivariate correlations examined associations between child age and ratings of 
child medical provider satisfaction or ratings of parent medical provider satisfaction, given that 
older children may have had more interaction with treatment providers, solely due to age. There 
were no significant relations for either (r = .02, p = .80; r = .09, p = .23, respectively). 
Therefore, child age was not included in any further analyses.  
Planned Analyses  
 
Variable reduction. A principal components analysis (PCA) with an orthogonal rotation 
was used to determine if there were latent components that emerged from the independent 
variables (perceptions of ADHD symptoms as externally controlled, parenting self-efficacy, 
stigma about ADHD, and misconceptions about ADHD). A Varimax rotation with Kaiser 
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normalization was conducted and the rotated component matrix was examined. Components with 
an eigenvalue > 1 were included as independent variables in hypothesis testing models. Index 
variables, called components, are created from a larger set of measured variables by using 
weighted averages of a set of variables.  
Correcting for inflation of family-wise error rates. To adjust for increased risk of Type 
I error when conducting multiple tests, the Bonferroni correction for family-wise error rates was 
used. Alpha (set at .05) was divided by the number of tests conducted (i.e., n = 4). Significance 
level was set at p < .0125. 
Hypothesis 1a: A linear regression will be conducted to determine if the latent 
components that emerged from the component analysis (i.e., Misunderstanding of ADHD and 
Susceptibility to ADHD Stigma) are associated with more negative attitudes about ADHD 
medication (as measured by the QATT). Components will be entered simultaneously.  
 Hypothesis 1b: A linear regression will be conducted to determine if positive parental 
ratings of satisfaction with their own and their child’s past treatment providers is associated with 
more positive ADHD medication attitudes. Satisfaction variables will be entered simultaneously. 
Hypothesis 1c: Using the SBAKS knowledge score to assess knowledge and responses 
to clinical vignettes to assess symptom recognition, a linear regression will be conducted to 
examine these factors’ association with attitudes towards ADHD medication. Both independent 
variables will be entered simultaneously.  
Hypothesis 2a: In the same process as in Hypothesis 1a, a linear regression will be 
conducted to examine if the latent components that emerged from the component analysis  are 
associated with time spent on the ADHD information page. A logistic regression will be 
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conducted to determine if these components are associated with seeking additional information 
about ADHD resources. 
Hypothesis 2b: Consistent with Hypothesis 1b, a linear regression will be conducted to 
examine the relation between parents’ satisfaction with their own or their child’s health providers 
and time spent on the ADHD information page. A logistic regression will be conducted to 
determine if previous satisfaction with providers is associated with seeking additional 
information about ADHD resources.  
Hypothesis 2c: Consistent with Hypothesis 1c, a linear regression will be conducted to 
examine if ADHD knowledge and symptom recognition are significantly associated with time 
spent on the information page. A logistic regression will be performed to determine if these 
factors are associated with seeking additional information about ADHD resources.  
Hypothesis 3: Finally, a linear regression will be used to examine if treatment-seeking 
attitudes about ADHD medication are associated with time spent on the ADHD information 
page. A logistic regression will be used to determine if treatment-seeking attitudes about ADHD 
medication are associated with seeking additional information about ADHD resources. Variables 
will be entered simultaneously. 
Results 
 See table 3 for results of factor analysis. See Tables 4 and 5 for complete hypothesis 
testing results.  
Variable reduction 
 Two distinct latent components emerged from the principal components analysis (see Table 3). 
Component 1 explained 36.87% of the variance (Eigen value = 1.48) and component 2 explained 
an additional 28.22% of the variance (Eigen value = 1.13). Perceptions of ADHD as externally 
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controlled and high misconceptions loaded on Component 1 (labeled, Misunderstanding of 
ADHD) and low parenting self-efficacy and high ADHD stigma loaded on Component 2 
(relabeled, Susceptibility to ADHD Stigma). Given the significant negative relation between 
parenting self-efficacy and ADHD stigma (r = -.30, p< .001), Susceptibility to ADHD Stigma 
was chosen to label this component. Individuals who have greater beliefs in their own abilities as 
parents may have less worries and fears about how others would view themselves or their child if 
their child had ADHD.  
Hypothesis 1a 
Misunderstanding of ADHD and susceptibility to ADHD stigma were not significantly 
associated with the total score on the QATT (r2  = .03, F(2,166) = 2.25, p = .11). Overall models 
for worries about treatment (r2  = .07, F(2,166) = 6.06, p =.003), insight into need for treatment 
(r2  = .08, F(2,166) = 7.38, p < .001), and self-perception/patient-doctor relation were significant 
(r2  = .15, F(2,166) = 14.23, p < .001).   
Regression analyses indicated that misunderstanding of ADHD was the component 
driving significance for worries about treatment (t = 3.30, β = .25, p < .001) and insight about 
treatment (t = -3.39, β = -.25, p < .001). Greater misunderstanding about ADHD was positively 
associated with worries about treatment and negatively associated with insight about treatment. 
For self-perception and patient-doctor relationship, results suggest that susceptibility to ADHD 
stigma drove the association (t = -5.35, β = -.38, p< .001). Less susceptibility to ADHD stigma 
was associated with greater self-perception and patient-doctor relationships in this non-
treatment-seeking sample of parents. 
Hypothesis 1b 
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 Regression analyses suggested that  one’s own or child’s medical provider was not 
associated with QATT total treatment attitudes (r2  = .01, F(2,166) = .53, p = .69) or self-
perception and patient-doctor relationships (r2  = .02, F(2,166) = 2.43, p = .09). The overall 
models for worries about treatment (r2  = .16, F(2,166) = 15.23, p < .001) and insight about need 
for treatment (r2 = .07, F(2,166) = 6.17, p = .003) were significant. 
 Results indicated that more positive experiences with a child’s providers was associated 
with lower worries about treatment (t = -3.02, β = -.27, p = .003). More satisfaction one’s own 
provider was associated with increased insight about treatment (t = 2.50, β = .24, p = .01) in this 
non-treatment-seeking sample of parents. 
 To better understand the unexpected finding that satisfaction with treatment providers 
was not associated with the QATT self-perception and patient-doctor relationships scale, a 
bivariate correlation was conducted to determine if, for this association, the two domains (i.e., 
self-perception, two questions vs. patient-doctor relationship, one question) in the QATT factor 
demonstrated differential relationships with previous provider experiences. A significant 
correlation between both satisfaction with one’s own provider (r = .36, p < .001) and child’s 
provider (r = .28, p < .001) was observed with endorsements of positive relationship with 
treatment providers. No significant correlations were observed between either satisfaction with 
own or child treatment providers and either of the two self-perception items of the factor (all ps  
> .17).  
Hypothesis 1c 
ADHD knowledge and symptom recognition were not significantly associated with 
QATT total treatment attitudes (r2  = .004, F(2,166) = .30, p = .74) or self-perception and patient-
doctor relationship (r2  = .001, F(2,166) = .10, p = .90). Knowledge and symptom recognition 
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trended towards significance with worries about treatment attitudes yet did not survive 
Bonferroni correction (r2  = .05, F(2,166) = 3.98, p = .02). ADHD knowledge and symptom 
recognition were significantly associated with insight about need for treatment (r2  = .12, 
F(2,166) = 11.40, p < .001). 
 Knowledge about ADHD drove the significant association in the model (t = 4.49, β = .36, 
p<.001); greater ADHD knowledge was associated with significantly more treatment insight in 
this non-treatment-seeking sample of parents. The trending significant relation in the worries 
about medication model was also driven by knowledge (t = -2.63, β = -.22, p = .01); lower 
ADHD knowledge was associated with more worries about treatment.  
Hypothesis 2a 
 The linear and logistic regressions indicated that misunderstanding of ADHD and 
susceptibility to ADHD stigma were not significantly associated with time spent on the ADHD 
information page (r2  = .002, F(2,166) = .19, p = .83) or seeking additional information about 
ADHD resources (Wald X2(2) = .37, p = .83). 
Hypothesis 2b 
Satisfaction with one’s own or child providers were not significantly associated with time 
spent on the ADHD information page (r2  = .03, F(2,166) = 2.26, p = .11) or seeking additional 
information about ADHD resources (Wald X2(2) = 2.39, p = .30). 
Hypothesis 2c 
ADHD knowledge and symptom recognition were not significantly associated with time 
spent on ADHD information page (r2  = .002, F(2,166) = .19, p = .83) or seeking additional 
information about ADHD resources (Wald X2(2) = 1.65, p = .44). 
Hypothesis 3 
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Linear regression indicated that QATT total treatment attitudes, worries about treatment, 
insight about need for treatment, and self-perception and patient-doctor relationship scales were 
not related to time spent on ADHD information page (r2  = .04, F(4,164) = 1.86, p = .12). 
Logistic regression indicated that QATT total treatment attitudes, worries about treatment, 
insight about need for treatment, and self-perception and patient-doctor relationship were not 
significantly associated with desire to learn more about ADHD resources (Wald X2(8) = 8.84, p 
= .36). 
Discussion 
Understanding the factors that predict ADHD treatment attitudes in a non-treatment-
seeking sample of parents was the primary goal of this study. While these parents were not 
currently seeking treatment for their child’s ADHD symptoms, at the group level, elevated levels 
of ADHD symptoms were reported (DuPaul et al., 2016). Likewise, a significant percentage of 
parents (40.8%) indicated that their child demonstrated global functional impairment (Fabiano et 
al., 2006). Misconceptions about ADHD and external attributions about the cause of ADHD 
were associated strongly with each another. Likewise, high stigma ratings and lower parenting 
self-efficacy were associated strongly with one another. 
Variables associated with treatment attitudes in other studies (Bennet et al., 1996; 
Johnston et al., 2008; Sciutto, 2015) were also predictive in a non-treatment-seeking sample of 
parents. In both treatment-seeking and non-treatment-seeking parents, attitudes towards ADHD 
treatment were best predicted by misunderstanding of ADHD, susceptibility to ADHD stigma, 
and satisfaction with past providers. In particular, in the current study, susceptibility to stigma, 
satisfaction with children’s providers, and knowledge about ADHD and ADHD treatments were 
significantly associated with different, yet important, aspects of treatment attitudes. 
  
44
Susceptibility to ADHD stigma was strongly related to poorer self-perceptions and patient-doctor 
relationships, satisfaction with a child’s past treatment provider was robustly associated with 
worries about treatment, and ADHD knowledge was strongly related to insight into the need for 
treatment. Attitudes towards ADHD treatment were not, however, predictive of seeking 
additional information about ADHD resources. This has a variety of implications for future 
research and clinical application related to current initiatives to increase evidence-based 
diagnosis and treatment contact. Further, the strongest relations highlighted in these results 
indicate avenues for altering various aspects of treatment attitudes.  
Hypothesis 1a – Predicting Attitudes About ADHD Medication   
Misunderstanding ADHD. Misunderstanding ADHD was associated positively with 
parental worries about treatment and associated negatively with parental insight about treatment. 
These findings are consistent with previous research which reported that mothers who viewed 
their own child’s ADHD symptoms as external / non-biological demonstrate disfavor for 
pharmacological treatments (Johnston et al., 2008). Likewise, others have reported that 
possessing misconceptions about ADHD and having low knowledge of ADHD is associated with 
lower acceptability ratings for ADHD medications (Bennet et al., 1996; Sciutto, 2015). Taken 
together, in both treatment-seeking and non-treatment-seeking samples, parents with a better 
understanding of ADHD and its evidence-based treatments have more positive medication 
treatment attitudes.  
Misunderstanding of ADHD (e.g., viewing ADHD as externally / non-biologically 
caused due to poor parenting) is associated with greater worries about ADHD treatment. 
Previous research suggests that parental recognition of symptoms or behavioral problems in their 
children is a strong predictor of accessing all types of services, yet many parents do not choose to 
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seek treatment, despite reporting elevated symptoms and impairment in their children (Sayal et 
al., 2006). That elevated ADHD symptoms and functional impairments were noted in this non-
treatment-seeking sample supports these previous findings. Not pursuing ADHD treatment 
despite elevated ADHD symptoms and impairment is likely due to a variety of factors related to 
misunderstanding of ADHD, including (a) the general public places more blame and 
responsibility on parents of children with ADHD for their child’s ADHD compared to parents of 
children with depression and asthma (Mukolo & Heflinger, 2011); (b) stimulant medications are 
viewed rather contentiously by the general public (Bussing & Gary, 2001); and (c) much 
misinformation exists about ADHD (Sage et al., 2017). 
Given that this non-treatment-seeking sample of parents reported elevated ADHD 
symptoms and functional impairments in their child and that greater misunderstanding of ADHD 
was associated with more negative attitudes towards treatment, future research should consider 
how best to improve understanding ADHD (e.g., that it is not caused by poor parenting) and 
knowledge of ADHD medications (e.g., does not increase risk for substance abuse). Further, 
feeling knowledgeable about a diagnosis helps parents to feel empowered in making treatment 
decisions (Hummelinck & Pollock, 2006). Parents often rely upon pediatric primary care 
providers, books and schools for information regarding ADHD (Sciberras, Iyer, Efron, & Green, 
2010). Thus, these future efforts to increase parental knowledge will likely include collaborating 
with pediatric primary care providers and school psychologists.  
Susceptibility to ADHD Stigma. Fear of stigma is the most commonly cited reason for 
not accessing mental health treatment in general (Gulliver et al., 2010) and ADHD specifically 
(Bussing et al., 2012). Fear of stigma is not only a barrier to accessing treatment, but is also a 
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contributing factor to parents ceasing evidence-based pharmacological treatment for their 
children (Ahmed et al., 2013; Kazdin et al., 1997).  
Susceptibility to ADHD stigma was associated with lower self-perception and poorer 
patient-doctor relationships. Parents with higher parenting self-efficacy may be resistant to the 
negative effects of stigma. While this topic has not been investigated in the ADHD parenting 
literature, in the non-ADHD literature, stigma resistance and self-efficacy are strongly related 
(Firmin, Luther, Lysaker, Minor, & Salyers, 2016).  
Parenting self-efficacy has been previously demonstrated to be related to lower 
acceptability of ADHD medication and the endorsement of behavioral treatment over ADHD 
medication (Jiang et al., 2014). Parents with higher parenting self-efficacy may feel as if they do 
not need to rely on medications (Johnston et al., 2010). Relatedly, an outcome of behavioral 
parent training programs for managing pediatric ADHD is enhanced parenting self-efficacy 
(Heath, Curtis, Fan, & McPherson, 2015). Thus, parenting self-efficacy and behavioral 
treatments for ADHD appear bidirectionally related.  
A parental preference for behavioral treatment demonstrated in previous studies (Jiang et 
al., 2014; Johnston et al., 2010) is not inherently negative. In fact, some data suggest that starting 
behavioral interventions before medication for ADHD management is associated with greater 
parental engagement in treatment and lower levels of treatment attrition (Pelham et al., 2016). 
Future studies should consider how parental self-efficacy and preferences for behavioral 
treatments in ADHD are associated with attitudes towards medication and how these preferences 
may change over time.   
Finally, with regard to patient-doctor relationships, parents with higher levels of 
parenting self-efficacy may feel in control of treatment decisions and empowered in interactions 
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with their doctors. Psychological empowerment refers to three inter-related dimensions (a) 
cognitive appraisals of self-efficacy, control, and competence, (b) knowledge and (c) 
participatory behaviors with others (Perkins & Zimmerman, 1995). Psychological empowerment 
has been previously noted to be associated with positive health outcomes (Florian & Elad, 1998) 
and more contentment with health related treatment decisions (Davison & Degner, 1997). Future 
research should consider the extent to which psychological empowerment helps to explain the 
relation between low stigma, high self-efficacy and positive patient-doctor relationships.  
The critical role of self-efficacy in psychological empowerment, the saliency of stigma as 
a barrier to treatment, the relationship between higher self-efficacy and lower stigma, and the 
associations between low susceptibility to stigma and greater self-perception and patient-doctor 
relationships highlight the need for initiatives to reduce susceptibility to stigma in non-treatment-
seeking parents of children with ADHD. Decreasing susceptibility to stigma may lead to greater 
health outcomes and greater contentment and engagement with treatment decisions, as well as 
decrease the delay to treatment for children with ADHD.  
Hypothesis 1b – The Impact of Previous Provider Relationships on ADHD Treatment 
Attitudes 
 In support of hypothesis 1b, more positive experiences with a child’s past treatment 
provider was significantly associated with lower worries about ADHD medication. Treatment-
seeking parents worry about the long-term effects of ADHD medications on their child’s 
development (Berger, Dor, Nevo, & Goldzweig, 2008; Hansen & Hansen, 2006). Further, 
parents prefer doctors who they view as diagnostic experts and provide psychoeducation (Coletti 
et al., 2012) and having a positive relationship and previous experiences with a child’s provider 
builds trust in the provider (King et al., 2015).  
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Conversely, parents’ positive experiences with their own provider were associated with 
increased insight about the need for medication treatment. Others have reported that personal 
previous successful experiences with treatment is associated with more positive treatment 
attitudes (Liu et al., 1991). This finding, in a non-treatment-seeking sample, suggests that these 
associations may exist for those not currently seeking treatment. Having a positive experience 
with previous treatment providers may engender a better understanding about treatment, its 
importance, and its safety. When parents had greater satisfaction with their own provider, they 
may have been more open to learning about ADHD assessment and treatment, feel more 
empowered to ask questions, or trust doctors as experts (Coletti et al., 2012; Ha & Longnecker, 
2010; Kraetschmer et al., 2004; Vermeire et al., 2001). This, in turn, was related to increased 
insight about treatment. 
Given that parents endorse worries about treatment (Berger et al., 2008) and often revisit 
their treatment decisions (Brinkman et al., 2009), along with results of the current study, 
reduction of worries about children’s treatment is of clinically significant import. The results of 
this study demonstrate the possibly critical role of parent-doctor relationships in increasing 
willingness to try ADHD treatment. 
Hypothesis 1c – ADHD Knowledge, Symptom Recognition and Medication Attitudes 
 Greater ADHD knowledge was associated significantly with more treatment insight in 
this non-treatment-seeking sample of parents. This replicates previous findings that individuals 
who are more knowledgeable about ADHD may have a better understanding about the 
effectiveness and appropriate use of medications, and thus, hold more positive attitudes towards 
these treatments (Bennet et al., 1996; Sciutto, 2015). The strong relationship between knowledge 
and insight about treatment demonstrate a critical avenue for increasing treatment contact. 
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 Contrary to previous research about symptom recognition and attitudes towards treatment 
(Mojtabai et al., 2011; Sayal et al., 2006), the ability to recognize symptoms of ADHD as 
characteristic of ADHD was not related to attitudes towards treatment. This may be due to the 
fairly high rate of symptom recognition in the sample (71.4% correct); previous research on 
barriers to treatment for other mental health disorders has found lower symptom recognition 
rates (e.g., 67.3% of adults are able to recognize symptoms of depression and 36.2% 
schizophrenia from similarly structured vignettes) (Jorm, Christensen, & Griffiths, 2006). The 
restricted variance in our sample may have reduced our power to detect differences.  
 In addition to this statistical explanation for these null findings, it is also possible that 
although these parents could recognize ADHD symptoms, this recognition did not impact 
attitudes towards treatment. This is consistent with previous research which has suggested 
despite recognizing the presence of ADHD symptoms, few parents access treatment for their 
children (Sayal et al., 2006). That ADHD symptom recognition and treatment attitudes were not 
related may also be a function of the non-treatment-seeking aspect of this sample. Factors not 
explored in this study (e.g., teacher input, level of spouse concern, etc.) may explain why parents 
can accurately recognize ADHD symptoms yet this recognition does not predict to treatment 
attitudes.  
Hypotheses 2a-2c, 3 – Predicting Behavior from Attitudes 
 Hypotheses about factors that might be significantly associated with time spent on the 
ADHD information page and seeking additional information about ADHD resources were 
unsupported. Although attitudes and behaviors are related (Crano & Prislin, 2011; Sheeran, 
2002), there are other factors that affect attitude such as vested interest (i.e., the attitude has 
noticeable and perceived direct or indirect effects on the individual) (Johnson, Siegel, & Crano, 
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2014). Given that child impairment was not related to time spent on the ADHD information 
page, and symptoms were only marginally related, parents may not have had a vested interest in 
the information, although arguably the information could be helpful to them.  
 Stewart, Pyke-Grimm, and Kelly (2005) propose a model of parental treatment decision-
making related to pediatric oncology. This model includes decision-making contextual factors 
and decision-making process factors. In this model, contextual factors include illness factors 
(e.g., prognosis/severity of illness), person factors (e.g., culture, education level), and 
relationship factors (e.g., trust in healthcare provider). These contextual factors affect process 
factors, which include the congruence between one’s preferred role in decision making (i.e., 
passive, collaborative, or active) and one’s actual role. These process factors affect decisional 
outcomes such as decisional conflict and satisfaction with decision (Stewart et al., 2005). This 
model can broadly be applied to ADHD as well. The current study focused on contextual factors, 
particularly person and relationship factors. Understanding other decision-making process factors 
that impact parents of children with ADHD is important, yet unexplored in the current study.  
The current study also did not examine illness factors, which may be important 
contextual factors in decision-making (Stewart et al., 2005). Other models of health-related 
decision-making also emphasize the importance of perceptions of disorders in decision-making. 
The health belief model (HBM) is one of the most influential theories for explaining health 
related behaviors. In this model, individual perceptions of the condition (severity, susceptibility) 
lead to perceived threat of the condition (Rosenstock, 1990). Perceived threat is moderated by 
demographic factors, social variables such as perceived peer pressure, knowledge of the 
condition, and cues to action (e.g., advice from others, having a family member treated for the 
condition, etc.). These factors predict to the likelihood of action. In this study, ADHD symptom 
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recognition levels were fairly high. The majority of parents correctly identified ADHD 
symptoms as being representative of ADHD. Despite rating their child as having elevated 
symptoms and impairments, however, these parents may not have perceived ADHD as “serious” 
or that their child was susceptible, which may have affected the treatment-seeking behavior 
process (Rosenstock, 1990; Stewart et al., 2005).  
In addition, the impact of social influences such as subjective or injunctive norms (Miller 
& Prentice, 1996), unexplored in this study, may help to explain the lack of a relation between 
attitudes and behaviors. Finally, others have suggested that parents prefer to have a dialogue with 
their pediatric primary care physician about the specific needs of their child rather than receive 
general educational information about ADHD (Sciberras et al., 2010). Some combination of the 
above models likely explains why associations between misunderstanding of ADHD, 
susceptibility to ADHD stigma, previous experiences with providers, and ADHD knowledge and 
symptom recognition were not predictive of actual behaviors (time spent on the ADHD 
information page and seeking additional information about ADHD resources).  
 The lack of an association between knowledge of ADHD and information-seeking 
behaviors stands in contrast to many public health initiatives for other health conditions (e.g., 
asthma, autism; note: not ADHD; to our knowledge, there is no public health initiative to 
increase knowledge of ADHD). Current efforts to increase treatment-seeking behaviors in other 
health conditions focus on providing information to correct misconceptions, reducing stigma, 
and increasing knowledge (Perry et al., 2014; Pinfold et al., 2003; Schachter et al., 2008; Spence 
et al., 2005; Watson et al., 2004; Wyn et al., 2000). The premise of these campaigns is that by 
increasing knowledge and decreasing stigma (i.e., two well-reported barriers to treatment-
seeking for mental health disorders), the delay to treatment will decrease. These present results 
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suggest that ADHD may be somewhat different and future attempts to increase information-
seeking behaviors should consider why.  
Limitations 
 There are several limitations to the current study that support the need for further 
investigation of this topic. First, the sample was mostly White, women, and highly educated. 
There is therefore need for replication in a more diverse sample to increase generalizability. For 
example, research on parents of children with ADHD indicates that the majority of parents use 
the internet for ADHD and ADHD medication information, but that White parents have more 
access to internet than parents of other races (Sage et al., 2017). Information-seeking behavior 
thus needs to be addressed in a more socioeconomic and racially diverse sample. 
Further examination of fathers and their role in treatment-seeking should also be 
considered. Fathers, like mothers, have an important role in child and adolescent development 
(Lamb, 2004; Phares, Lopez, Fields, Kamboukos, & Duhig, 2005b). Nonetheless, fathers’ roles 
in the treatment, etiology, and course of pediatric mental health disorders is an under-researched 
and poorly understood topic (Bögels & Phares, 2008; Lamb, 2004; Phares, Fields, Kamboukos, 
& Lopez, 2005a; Phares et al., 2005b). A review of the literature of fathers in chronic medical 
conditions suggests that compared to mothers, fathers use fewer coping strategies, exhibit more 
psychological symptoms in response to a child’s chronic condition and provide lower levels of 
encouragement to their daughters (Phares et al., 2005b). Relatedly, there is a need to understand 
what differential opinions, effects, and responsibilities, if any, exist in the treatment-seeking 
roles of fathers and mothers for their child’s ADHD. Replication and extension of the current 
study in a more balanced sample may provide more insight into what differences in attitudes and 
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behaviors may occur between mothers and fathers and how these differences and interactions 
may affect a child’s access to evidence-based treatment. 
Although there was evidence for significant associations between hypothesized factors 
and treatment attitudes, there was still significant variance unaccounted for in the models. The 
transtheoretical model cites six stages of change (e.g., treatment-seeking behaviors) including 
precontemplation, contemplation, preparation, action, maintenance, and termination (Prochaska 
& Velicer, 1997). Individuals who never, or delay to, seek treatment may stagnate in one of these 
first three stages (i.e., precontemplation, contemplation, preparation). Although not explicitly 
measured, given the non-treatment-seeking nature of the sample, parents were likely in the 
precontemplative, contemplative, or preparation stage of change. 
As suggested by the transtheoretical model, stage of readiness to change may affect what 
factors are most salient for an individual (Prochaska & Velicer, 1997). Stage-matched 
interventions may be most beneficial for reaching at-risk populations (Prochaska & Velicer, 
1997). Undoubtedly, there is still need to examine significant predictors of treatment attitudes 
beyond what the current study considered and stage of readiness to change likely represents one 
of these predictors. There is also need for longitudinal work to understand the dynamic nature of 
treatment attitudes and behaviors over time. Future research should consider how stage of change 
affects treatment attitudes (and vice versa). The current child sample was symptomatic, yet 
untreated and therefore, considering how parental attitudes, and ultimately decisions, may 
change across stages of change may enable a better understanding of parents’ treatment attitudes. 
Better understanding this variance may lead to the development of more targeted intervention 
efforts towards increasing children’s access to evidence-based treatment.  
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 This study also may have been low in ecological validity. Participants may not have 
responded or behaved the same way they would in real life. There were possible demand 
characteristics (e.g., social desirability) that may have affected results. However, given the 
anonymous nature of the survey (i.e., conducted in the privacy of their own homes) participants 
may have been more resistant to these effects. Further, participants may have been motivated to 
simply complete the study, rather than seek additional information, and therefore did not seek 
additional information (mock webpage presented at the end of the survey), despite having some 
interest in the topic. The current study measured time spent on the information page as well as 
seeking more information about treatment resources Attention to, and comprehension of, the 
ADHD information was not recorded. On the other hand, it is possible that the survey primed 
individuals to be concerned about ADHD. The measures were presented in the same order to 
every participant to ensure adequate completion of critical variables (e.g., demographics), but 
this may have led to unintended effects of seeking additional information despite having low 
interest.  However, given the low rate of desire for more information, this seems unlikely.  
 Information-seeking behavior was chosen as a measure of treatment-seeking behavior 
due to the importance of knowledge as a facilitator to treatment (Bennet et al., 1996; Sciutto, 
2015). Additionally, evidence that suggests that parents of children with ADHD rely on (often 
inaccurate) online information to answer their questions about their child’s ADHD (Sage et al., 
2017). Furthermore, measures used in previous studies (e.g., What types of websites do you used 
to gather information [about ADHD]?) (Sage et al., 2017) may not be as relevant to non-
treatment-seeking parents as they may not be gathering information about ADHD. By presenting 
parents with factual information about ADHD and ADHD treatment, while recording time spent 
on the mock webpage and also providing opportunity to learn more about resources, the current 
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study was able to objectively measure one aspect of information-seeking that was not related to 
parents’ past behaviors. However, information-seeking certainly does not encompass or represent 
all types of treatment-seeking-relevant behaviors. Other behaviors, such as decision to take an 
ADHD screener if prompted, set up appointments with assessment providers, and reactions to 
treatment provider-initiated conversations about ADHD assessment may also be important 
behaviors to understand. Further investigation of these behaviors, as well as how they may relate 
to treatment contact, is likely important.  
 The QATT (Ferrin et al., 2012), which was used as a main outcome measure in the 
current study, demonstrated low internal consistency in this sample. Although this measure has 
been well validated in treatment-seeking populations, this measure has not been used in non-
treatment-seeking samples. Low internal consistency in this sample may indicate that validated 
factors that emerged in a treatment-seeking sample (Ferrin et al., 2012), may not be 
representative of unitary constructs in a non-treatment-seeking sample. Validation of the QATT 
in a non-treatment-seeking sample, following similar procedures to the validation methods 
described by Ferrin et al. (2012) and confirmatory and exploratory factor analyses may shed light 
on possibly different factors of treatment analyses.  
Further, the QATT may characterize some, but not all, relevant treatment attitudes in a 
non-treatment-seeking sample. Therefore, there may be reason for future research to validate or 
develop additional measures of treatment attitudes in non-treatment-seeking samples. For 
example, the QATT primarily focuses on internally-focused treatment attitudes (e.g., “I am 
worried about taking this medication”), but externally-focused treatment attitudes (e.g., “Parents 
who use ADHD medications are lazy”) may also be salient as barriers to treatment for non-
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treatment-seeking parents. Future validation and examination of treatment attitudes in this 
population is likely important to understanding treatment attitudes.  
Directions for Future Research and Implications for Clinical Practice  
The current study began the process of unraveling the complicated nature of barriers to 
treatment through understanding treatment attitudes and information-seeking behaviors in a non-
treatment-seeking sample of parents. There are a variety of future directions for this area in 
addition to those noted above particularly in light of the large associations between susceptibility 
to ADHD stigma and self-perceptions and patient-doctor relationships, satisfaction with a child’s 
past provider and worries about treatment, and knowledge and insight into the need for 
treatment. These three areas represent the strongest associations in the current study, highlighting 
possible areas for focus in interventions to reduce barriers to treatment among these three 
different factors of treatment attitudes. 
Currently, campaigns that aim to increase knowledge and decrease barriers to treatment 
are reliant on providing information (Perry et al., 2014; Pinfold et al., 2003; Schachter et al., 
2008; Spence et al., 2005; Watson et al., 2004; Wyn et al., 2000). Given the results of the current 
study that low knowledge, high misunderstandings of ADHD, and susceptibility to stigma are all 
related to more negative treatment attitudes, and particularly that knowledge was robustly related 
to insight about the need for treatment, the provision of information seems a logical way to try to 
change treatment attitudes. However, campaigns that market themselves as providing more 
information may not reach their target audiences. The results of the current study suggest that 
those who may benefit from these campaigns (i.e., those with lower levels of knowledge and 
understanding about ADHD and ADHD treatments and higher levels of stigma) were no more 
likely to be receptive to or seek addition information than those with higher levels of knowledge.  
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Thus, more targeted interventions may be beneficial to consider. In the current study, 
parents whom rated their child as more impaired sought more information about ADHD 
resources than parents whom did not desire more information. Nonetheless, the amount of time 
parents spent on the ADHD information page was not related to their ratings of their child’s 
functional impairment. The results of this study suggest there was a wide range of time spent on 
the ADHD information page, yet this range was not explained by parents’ views of their child as 
being impaired. It is possible that parents may not view their child as more impaired or 
symptomatic compared to the average child, thus they were unaware that resources may have 
been of benefit. If neither child impairment nor low knowledge is related to parents spending 
time on the ADHD information page, currently existing efforts to increase access to evidence-
based treatment may need to be reconsidered.  
The current study measured one aspect of treatment-seeking behavior (i.e., information-
seeking). There are a variety of other relevant treatment-seeking behaviors that future research 
should consider. For example, parents’ acceptance and response to treatment provider inquiries 
related to providing psychoeducation about ADHD or other mental health / neurodevelopmental 
disorders, response to campaigns to reduce barriers to mental health treatments, willingness to 
take a screening tool for ADHD or other neurodevelopmental / mental health disorders, 
willingness to schedule an appointment with a treatment provider in response to results on a 
screener, and other treatment-seeking behaviors may all be relevant and clinically important to 
examine.  
A significant body of work to increase evidence-based ADHD diagnosis and treatment 
focuses not on parents, but rather upon increasing pediatrician and primary care providers’ 
evidence-based practice (Carroll et al., 2013; Co et al., 2010; Epstein et al., 2016; Epstein et al., 
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2011; Epstein et al., 2008; Epstein et al., 2007; Geltman et al., 2015; Lavigne et al., 2011; Olson, 
Rosenbaum, Dosa, & Roizen, 2005). Although some of this work does aim to increase shared 
decision-making (Brinkman et al., 2013), a majority of these interventions focus on how to 
increase pediatric primary care provider ADHD assessment and treatment monitoring practices 
to be in line with American Academy of Pediatrics (AAP) practice parameters. Given the low rate 
of adherence to evidence-based practice guidelines for primary care providers (e.g., 4% 
adherence to AAP guidelines) (Olson et al., 2005) and the critical role that primary care providers 
play in access to evidence-based treatment (Martini et al., 2012), this line of research is 
important. However, in light of the current findings, these pediatric primary care interventions 
may benefit from increased emphasis on teaching primary care providers about the many and 
varied barriers to treatment, factors associated with attitudes, and specific practices that might 
increase parents’ willingness to seek resources. For example, these programs may highlight not 
only the provision of psychoeducation, but also the importance of addressing past provider 
experience and maintaining a strong patient-doctor relationship (Coletti et al., 2012; Ha & 
Longnecker, 2010; Kraetschmer et al., 2004; Vermeire et al., 2001).  
Evidence that lower susceptibility to stigma is related to more positive treatment attitudes 
highlights the need for additional attention in this area. Efforts to decrease ADHD stigma and 
increase parenting self-efficacy may increase perceptions that ADHD treatment-seeking is a 
socially acceptable behavior. Moreover, previous research in other clinical samples suggests that 
perceived stigma is related to both lower self-efficacy and poorer coping with a disorder (Kleim 
et al., 2008). Accordingly, decreasing stigma and fostering self-efficacy may be important both 
for increasing treatment-seeking, but also for increasing one’s ability and resilience to the 
symptoms and negative effects of having a child with a mental health disorder. Treatment 
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providers should be mindful of assessing and addressing parenting self-efficacy as well as 
ADHD stigma. Existing questionnaires and surveys exist, including the parenting self-efficacy 
scale (Suzuki et al., 2009), the ASQ (Kellison et al., 2010), and QATT (Ferrin et al., 2012) used 
in the current study. Information from these questionnaires may increase pediatric treatment 
providers understanding of which barriers may be most salient for their patients and patients’ 
parents. Integration of education about the effectiveness and safety of medication, when 
appropriate, as well as attempts to increase parental resistance to stigma may both be important 
in increasing treatment-seeking behaviors.  
While increasing effective psychoeducation and resistance to stigma is likely important, 
the results of the current study suggest that although these aspects are important to treatment 
attitudes, actual information-seeking behavior may be influenced by other variables and 
motivations. Ryan and Deci (2000) highlight the importance of applying self-determination 
theory (Ryan, Kuhl, & Deci, 1997) towards enhancing treatment-seeking and treatment 
engagement. Given the findings of the current study, inclusion of basic principles of self-
determination theory, such as reinforcing autonomy and increasing motivation, may be fruitful 
towards increasing parents’ treatment-related behaviors. 
Finally, treatment providers should be aware of the effects of past treatment providers on 
parents’ treatment attitudes. Exploration of these past experiences may help build patient-doctor 
relationships and increase positive treatment attitudes. A simple inclusion of this question in 
intake or assessment paperwork may help treatment providers better understand how parents may 
feel about treatment providers in general and thus parents’ treatment attitudes. Given parents 
ratings of the importance of thorough psychoeducation (Coletti et al., 2012) and effective doctor 
communication (Ha & Longnecker, 2010),  the possible importance of congruence between 
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parents’ actual and desired role in the decision-making process (Stewart et al., 2005), the large 
associations between susceptibility to ADHD stigma and self-perception / patient-doctor 
relationship and between satisfaction with a child’s past providers and worries about treatments, 
treatment providers may wish to include more time spent discussing not only ADHD and 
treatment, but also focusing on relationship building, discussion / clarification of preferred and 
necessary parent-doctor roles, and building resistance to stigma.  
Conclusions 
Childhood ADHD is a common and impairing neurodevelopmental disorder with long-
term negative outcomes in a variety of domains (Barkley et al., 2006; Molina et al., 2009). 
Despite the prevalence of safe and effective treatments for ADHD (Faraone, 2003; Faraone & 
Buitelaar, 2010; Shaw et al., 2012), there is a significant delay to treatment and a low rate of 
lifetime treatment contact for individuals with ADHD (Dakwar et al., 2014). There are a wide 
variety of barriers to treatment such as misconceptions about ADHD and uncertainty of where to 
go for help (Bussing et al., 2003; Partridge et al., 2014). 
Most research on barriers to treatment for ADHD have focused either on hypothetical 
case vignettes (i.e., unrelated to one’s own child) or samples of parents who have already made 
the decision to seek treatment. The current study examined a non-treatment-seeking sample to 
determine what barriers to treatment may be salient to those who have not yet, or may never, 
seek treatment for ADHD. Consistent with previous research, the current study found that 
knowledge and understanding about ADHD and ADHD treatments (Partridge et al., 2012, 2014; 
Sciutto, 2015), resistance to stigma (Ahmed et al., 2013; Johnston et al., 2008), and positive 
experience with past providers (Liu et al., 1991) were significantly related to positive attitudes 
about treatment. Nonetheless, despite finding significant associations between hypothesized 
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factors and treatment attitudes, models assessing relations with information-seeking behavior 
were non-significant.  
Additional research on factors associated with treatment attitudes as well as continued 
attention to development and assessment of efforts to increase treatment attitudes is warranted. 
Future research should continue to explore how poor understanding of ADHD, stigma about 
ADHD, low parenting self-efficacy and previous relationships with providers predict to not just 
treatment attitudes, but also treatment behaviors. As the current study highlighted, investigation 
of barriers is important to consider in a non-treatment-seeking sample, given the prevalence of 
ADHD symptoms and impairment demonstrated in children whose parents who are not currently 
accessing evidence-based treatment
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Figure 1 
Hypotheses and Data Analysis of the Current Study 
Hypothesis Independent Variables Analyses Hypotheses 
1a Perceptions of symptoms as externally 
controlled, parental self-efficacy, stigma, 
and misconceptions 
Exploratory PCA  
Linear regression 
Associated with negative treatment attitudes 
(QATT) 
1b Greater satisfaction with past treatment 
provider for self or child  
 
Linear regression Associated with positive treatment attitudes 
(QATT)  
1c Symptom recognition and knowledge Linear regression Associated with positive treatment attitudes 
(QATT)  
2a Misconceptions and stigma 
Self-efficacy, externally controlled 
symptoms 
Linear regression 
Logistic regression 
Negatively associated with information-
seeking behavior 
Positively associated with information-
seeking behavior 
2b Greater satisfaction with past treatment 
provider for self or child  
 
Linear regression 
Logistic regression 
Positively associated with information-
seeking behavior 
2c Symptom recognition and knowledge Linear regression 
Logistic regression 
Positively associated with information-
seeking behavior 
3 Positive treatment attitudes Linear regression 
Logistic regression 
Positively associated with information-
seeking behavior 
Note. QATT = Questionnaire about Attitudes Towards Treatment 
            PCA = Principal Components Analysis 
 
 
  
63
Table 1 
Demographic, Predictor, and Outcome Variables  
 
  
Camp 
(N=36) 
  
mTurk 
(N=133) 
        
Total 
(N=169) 
  
Variable M (SD) % M (SD) % F η2 χ2 M (SD) % 
Age 
42.44 
(6.93)  
39.41 
(9.62)  
2.98 .01 
 
40.00 
(9.22)  
Gender 
 
2.80% 
Men  
33.10% 
Men   
13.32*** 
 
26.60% Men 
Race 
 
100.00 % 
White  
91.00% 
White   
0.39 
 
92.90% White 
Education 
 
92.20% 
Some 
College 
Education 
 
82.70% 
Some 
College 
Education 
  
6.54** 
 
85.80% Some 
College 
Education 
Parent Number of 
Mental Illnesses 
0.28 
(0.68)  
0.48 
(0.75)  
2.12 .007 
 
0.44 
(0.74)  
Parent ADHD 
96.88% 
no  
96.90% 
no      
96.89% no 
PHQ Anxiety 
3.13 
(1.65)  
3.28 
(1.57)  
0.28 .001 
 
3.25 
(1.59)  
PHQ Depression 
2.55 
(1.18)  
3.03 
(1.40)  
3.89 .01 
 
2.93 
(1.37)  
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ASRS 
7.53 
(3.68)  
7.55 
(4.82)  
0.00 .000 
 
7.54 
(4.59)  
Ratings of 
Satisfaction with  
Any Adult 
Treatment 
Provider 
4.08 
(0.60)  
3.68 
(0.79)  
8.55** .03 
 
3.77 
(0.77)  
Number of 
Children 
2.06 
(0.67)  
2.05 
(1.08)  
0.00 .000 
 
2.05 
(1.00)  
Child Age 
10.14 
(4.23)  
10.03 
(8.94)  
0.01 .000 
 
10.06 
(8.18)  
Child Gender 
 
44.40% 
Boys  
49.60 % 
Boys   
0.350 
 
48.5% Boys 
ADHD-RS-5 
Total      
Percentile 
68.64 
(28.37)  
71.79 
(28.11)  
.35 .002 
 
71.11 
(28.11)  
ADHD-RS-5 
Hyperactivity 
Percentile 
70.36 
(23.66)  
72.63 
(26.89)  
.44 .003 
 
72.94 
(26.20)  
ADHD-RS-5 
Inattention 
Percentile 
63.67 
(28.74)  
69.21 
(28.37)  
1.08 .006 
 
68.03 
(28.45)  
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Global 
Impairment on 
IRS 
1.61 
(1.71)  
1.62 
(1.67)  
0.00 .000 
 
1.62 
(1.68) 
 
 
Ratings of 
Satisfaction with  
Any Child 
Treatment 
Provider 
4.22 
(0.44)  
3.81 
(0.89)  
6.95** .02 
 
3.90 
(0.86)  
Perceptions of 
ADHD as 
externally 
controlled 
0.43 
(0.44)  
0.46 
(0.54)  
0.10 .000 
 
0.46 
(0.52)  
Knowledge 
19.12 
(2.79)  
18.52 
(2.78)  
1.49 .005 
 
18.65 
(2.79)  
Misconceptions 
6.88 
(2.79)  
7.48 
(2.78)  
1.49 .005 
 
7.35 
(2.79)  
Parenting Self-
Efficacy 
134.26 
(12.16)  
132.30 
(13.53)  
0.69 .002 
 
132.72 
(13.24)  
ASQ Total 
Stigma 
53.62 
(12.38)  
50.57 
(15.87)  
1.24 .004 
 
51.22 
(15.21)  
QATT Total 
70.27 
(9.01)  
68.63 
(10.11)  
0.89 .003 
 
68.98 
(9.88)  
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QATT Worries 
about Medication 
11.00 
(3.06)  
12.03 
(4.05)  
2.13 .007 
 
11.81 
(3.87)  
QATT Insight 
about Medication 
12.36 
(4.18)  
11.70 
(4.54)  
0.69 .002 
 
11.84 
(4.46)  
QATT Self-
Perception and 
Patient-Doctor 
Relationship 
8.82 
(2.09)  
8.13 
(2.26)  
3.06 .01 
 
8.27 
(2.24)  
ADHD Symptom 
Recognition  
71.43% 
correct  
71.43% 
correct   
0.17 
 
71.43% correct 
Time Spent on 
ADHD 
Information Page 
(Seconds)  
20.57 
(23.18)  
24.15 
(27.95)  
0.85 .003 
 
23.45 
(27.06)  
Requested more 
Information 
  
5.60% 
Yes 
  
12.80% 
Yes 
    0.86   11.20% Yes 
Note. PHQ = Patient Health Questionnaire  
ASRS = Adult ADHD Self-Report Scale  
IRS = Impairment Rating Scale 
ADHD-RS-5 = The 5th Edition ADHD Rating Scale 
ASQ = Attention Deficit Hyperactivity Disorder (ADHD) Stigma Questionnaire  
QATT = Questionnaire about Attitudes Towards Treatment 
* p < 0.05, ** p < 0.01, *** p < 0.001 
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Table 2 
Correlation Matrix of Outcome Variables 
  Hypothesis 1a, 2a Hypothesis 1b, 2b Hypothesis 1c, 2c Hypothesis 3 
Variable 
Misunder-
standing of 
ADHD 
Suscept-
ibility to 
ADHD 
Stigma 
Satisfaction 
with Own 
Provider 
Satisfaction 
with Child's 
Provider 
Knowledge 
about 
ADHD 
ADHD 
Symptom 
Recogni-
tion 
Worries 
about Treat-
ment 
Insight 
about 
Treat-
ment 
Self-
Perception 
and Patient-
Doctor 
Relation-
ship 
         
Total 
Misunder-
standing of 
ADHD 
1.00 .02 -.21** -.18* -.80** -.47** .25** -.25** .003 .12 
Suscepti-
bility to 
ADHD 
Stigma 
 1.00 -.03 -.10 .09 .06 .08 .13 -.38** .11 
Satisfaction 
with Own 
Provider 
  1.00 .61** .23** .15 -.33** .26** .15 -.04 
Satisfaction 
with 
Child's 
Provider 
   1.00 .16* .16* -.37** .19* .15* -.08 
Knowledge 
about 
ADHD 
    1.00 .43** -.21** .35** .025 -.06 
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ADHD 
Symptom 
Recognitio
n 
     1.00 -.08 .12 -.01 .01 
Worries 
about 
Treatment 
      1.00 -.19* .05 .56** 
Insight 
about 
Treatment 
       1.00 -.09 .38** 
Self-
Perception 
and 
Patient-
Doctor 
Relationshi
p 
        1.00 .15* 
Total 
Treatment 
Attitudes 
        
 
1.00 
Note: * p < 0.05, ** p < 0.01, *** p < 0.001           
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Table 3. 
Component Loadings and Communalities for the SBAKS Misconceptions, Perceptions of ADHD as Externally Controlled, ADHD 
Stigma, and Parenting Self-Efficacy 
 
  Component 
Misunderstanding 
of ADHD 
Susceptibility to 
ADHD Stigma 
1 2 
CAS External 
Attributions 0.76 0.22 
SBAKS 
Misconceptions 0.80 -0.11 
ADHD Stigma 0.29 0.74 
Parenting Self-
Efficacy 0.15 -0.82 
Note. CAS = Causal Attributions Scale 
SBAKS = Strength in Beliefs about ADHD Scale 
Principal Components Analysis with Varimax Rotation 
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Table 4  
Results of Linear Regressions 
 
Hypothesis  Variable   β t R R2 F p VIF 
1a 
  
QATT 
Total 
Model 
  
.16 .03 2.25 .11 
 
Misunderstanding 
of ADHD 
.12 1.54 
   
.13 1.00 
Susceptibility to 
ADHD Stigma 
.11 1.43 
   
.17 1.00 
QATT 
Worries 
Model 
  
.26 .07 6.06 .003 
 
Misunderstanding 
of ADHD 
.25 3.30 
   
.001 1.00 
Susceptibility to 
ADHD Stigma 
.08 1.05 .29 
  
.15 1.00 
QATT 
Insight 
Model 
  
.29 .08 7.38 .001 
 
Misunderstanding 
of ADHD 
-.25 -3.39 
   
.001 1.00 
Susceptibility to 
ADHD Stigma 
.14 1.87 
   
.06 1.00 
QATT 
Self-
perception 
and 
Patient-
Doctor 
Model 
  
.38 .15 14.23 .000 
 
Misunderstanding 
of ADHD 
.01 .14 
   
.89 1.00 
Susceptibility to 
ADHD Stigma 
-.38 -5.35 
   
.000 1.00 
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1b 
  
QATT 
Total 
Model     .08 .006 .53 .69   
Satisfaction with 
Provider 
.02 .23 
   
.84 1.59 
Satisfaction with 
Child Provider 
-.09 -.92 
   
.36 1.59 
QATT 
Worries 
Model 
  
.39 .16 15.23 .000 
 
Satisfaction with 
Provider 
-.16 -1.82 
   
.07 1.59 
Satisfaction with 
Child Provider 
-.27 -3.02 
   
.003 1.59 
QATT 
Insight 
Model 
  
.26 .07 6.17 .003 
 
Satisfaction with 
Provider 
.24 2.50 
   
.01 1.59 
Satisfaction with 
Child Provider 
.04 .43 
   
.66 1.59 
QATT 
Self-
perception 
and 
Patient-
Doctor 
Model 
  
.03 .02 2.43 .09 
 
Satisfaction with 
Provider 
.09 .91 
   
.37 1.59 
Satisfaction with 
Child Provider 
.10 1.04 
   
.30 1.59 
1c 
  
QATT 
Total 
Model     .06 .004 .30 .74   
Knowledge  -.08 -.95 
   
.34 1.23 
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Symptom 
Recognition 
.05 .60 
   
.55 1.23 
QATT 
Worries 
Model 
  
.21 .05 3.98 .02 
 
Knowledge  -.22 -2.63 
   
.01 1.23 
Symptom 
Recognition 
.02 .23 
   
.82 1.23 
QATT 
Insight 
Model 
  
.35 .12 11.40 .000 
 
Knowledge  .36 4.49 
   
.000 1.23 
Symptom 
Recognition 
-.04 -.49 
   
.63 1.23 
QATT 
Self-
perception 
and 
Patient-
Doctor 
Model 
  
.04 .001 .10 .90 
 
Knowledge  .04 .42 
   
.67 1.23 
Symptom 
Recognition 
-.03 -.31 
   
.76 1.23 
2a 
Time Spent 
on Page 
Model     .05 .002 .19 .83   
Misunderstanding 
of ADHD 
-.02 -.29 
   
.78 1.00 
Susceptibility to 
ADHD Stigma 
.04 .54 
   
.59 1.00 
2b 
Time Spent 
on Page 
Model     .16 .03 2.26 .11   
Satisfaction with  
Provider 
-.12 -1.19 
   
.24 1.59 
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Satisfaction with 
Child Provider 
-.07 -.67 
   
.50 1.59 
2c 
  
Time Spent 
on Page 
  
Model     .05 .002 .19 .83   
Knowledge  0.01 -0.05 
   
.96 1.23 
Symptom 
Recognition 
0.05 0.57       .57 1.23 
3 
Time Spent 
on Page 
Model   .21 .04 1.85 .12  
QATT Total .10 .82    .42 2.37 
QATT Worries .11 .98    .33 2.02 
QATT Insight .07 .68    .50 1.68 
QATT Self-
perception and 
Patient-Doctor 
-.08 -1.04    .30 1.07 
Note. QATT = Questionnaire about Attitudes Towards 
Treatment 
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Table 5  
Results of Logistic Regressions 
 
 
Hypothesis 
Dependent 
Variable 
β SE  Wald χ2 Nagelkerke R2 p 95% CI 
2a Model 
   
.004 .83 
 
 
Misunderstanding 
of ADHD 
.12 .25 .25 
 
.62 .69 - 1.86 
  
Susceptibility to 
ADHD Stigma 
-.08 .24 .12 
 
.73 .58 - 1.47 
2b Model       .02 .30   
 
Satisfaction with  
Provider 
-.17 .39 .18 
 
.67 .39 - 1.83 
  
Satisfaction with 
Child Provider 
.48 .34 2.04   .15 .83 - 3.12 
2c Model       .01 .44   
 
Knowledge  -.03 .10 .09 
 
.77 .81 - 1.17 
  
Symptom 
Recognition 
.39 0.3 1.64   .20 .82 - 2.66 
3 Model       .03 .36   
 
QATT Total .05 .04 1.66 
 
.20 .98 - 1.13 
 
QATT Worries -.15 .09 2.52 
 
.11 .72 – 1.04 
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QATT Insight -.01 .07 .01 
 
.91 .87 - 1.14 
  
QATT Self-
perception and 
Patient-Doctor 
.11 .11 1.02   .31 .90 – 1.40 
Note. QATT = Questionnaire about Attitudes Towards Treatment 
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